<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Hepatology International via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Hepatology International' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Hepatology+International&t=Hepatology+International&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 18:15:41 +0100</lastBuildDate>
        <item>
            <title>Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients</title>
            <link>http://www.medworm.com/index.php?rid=5668199&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl2xqk46271598g48%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that endotoxin and IL-6 may contribute to cirrhosis-associated PH. In this regard, modulation of these
 substances could improve pulmonary pressures in cirrhotic patients.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s12072-011-9337-0Authors
		Georgios N. Kalambokis, First Division of Internal Medicine and Hepato-Gastroenterology Unit, Medical School of Ioannina, University Hospital, 45110 Ioannina, GreeceAthanasia Mouzaki, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, GreeceMaria Rodi, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, GreeceKonstantinos Pappas, Department of Cardiology, University Hos...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668199</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:50 +0100</pubDate>
            <guid isPermaLink="false">5668199</guid>        </item>
        <item>
            <title>A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5649453&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp475232255443357%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We developed an objective, pertinent, and sensitive prognostic scoring system that predicted the 3-month mortality of patients
 with ACLFB with greater accuracy than the MELD.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s12072-011-9335-2Authors
		Yu-Bao Zheng, Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-Sen University, Tianhe Road 600# Gangding, Guangzhou City, 510630 People’s Republic of ChinaShi-Bin Xie, Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-Sen University, Tianhe Road 600# Gangding, Guangzhou City, 510630 People’s Republic of ChinaDong-Ying Xie, Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-Sen University, Tianhe Road 600# Gangdi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649453</comments>
            <pubDate>Sat, 28 Jan 2012 16:51:45 +0100</pubDate>
            <guid isPermaLink="false">5649453</guid>        </item>
        <item>
            <title>The 22nd Conference of the Asian Pacific Association for the Study of the Liver</title>
            <link>http://www.medworm.com/index.php?rid=5639175&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2m50581774558787%2F</link>
            <description>Content Type Journal ArticleCategory AbstractsPages 1-21DOI 10.1007/s12072-011-9330-7

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 6
	
		Journal Issue Volume 6, Number 1 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639175</comments>
            <pubDate>Wed, 25 Jan 2012 18:14:41 +0100</pubDate>
            <guid isPermaLink="false">5639175</guid>        </item>
        <item>
            <title>Hypoxic hepatitis: a challenging diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=5598896&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F378v6014l113r378%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypoxic hepatitis (HH), one of the most common causes of acute liver injury, has a prevalence of up to 10% of admissions in
 intensive care units across the world. Inadequate oxygen uptake by the hepatocytes resulting in centrilobular necrosis associated
 with abnormally raised levels of the serum transaminases (ALT, AST) in patients with clinical history of cardiac, respiratory,
 or circulatory failures is the key feature of this condition. Abstracts, reviews, case reports, and research letters from
 various sources such as Pubmed, Proquest, Ovid, Google Scholar, and ISI Web of Knowledge dating from 1970 to 2011 were read
 and analyzed thoroughly. A study of 100 patients with HH, carried out from 2009 to 2010 at Tongji Hospital of Tongji University,
 Shanghai, People...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598896</comments>
            <pubDate>Sat, 14 Jan 2012 16:41:44 +0100</pubDate>
            <guid isPermaLink="false">5598896</guid>        </item>
        <item>
            <title>The long way toward understanding host and viral determinants of therapeutic success in HCV infection</title>
            <link>http://www.medworm.com/index.php?rid=5598897&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkq8356v113663602%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-5DOI 10.1007/s12072-011-9339-yAuthors
		Pierre-Alain Rubbo, INSERM U1058, CHU Montpellier and Montpellier 1 University, Montpellier, FrancePhilippe Van de Perre, INSERM U1058, CHU Montpellier and Montpellier 1 University, Montpellier, FranceEdouard Tuaillon, INSERM U1058, CHU Montpellier and Montpellier 1 University, Montpellier, France
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5598897</comments>
            <pubDate>Fri, 13 Jan 2012 16:50:53 +0100</pubDate>
            <guid isPermaLink="false">5598897</guid>        </item>
        <item>
            <title>Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy</title>
            <link>http://www.medworm.com/index.php?rid=5583593&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4851gn5g7k020130%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Ascites is often seen in HCC patients and is associated with both tumoral and cirrhosis factors and decreased long-term survival.
 The CLIP staging system is a more feasible prognostic model for HCC patients with ascites. The optimal treatment strategy
 for these patients remains to be investigated.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s12072-011-9338-zAuthors
		Chia-Yang Hsu, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, 112 TaiwanYun-Hsuan Lee, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, 112 TaiwanYi-Hsiang Huang, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, 112 Taiwan...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583593</comments>
            <pubDate>Sat, 07 Jan 2012 16:52:02 +0100</pubDate>
            <guid isPermaLink="false">5583593</guid>        </item>
        <item>
            <title>Model systems and clinical applications of hepatic stem cells for liver regeneration</title>
            <link>http://www.medworm.com/index.php?rid=5538854&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F84h12501806676n5%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;With the accumulation of innovative and creative works, hepatic stem cells therapy will be a new approach for liver diseases.
 
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-12DOI 10.1007/s12072-011-9323-6Authors
		Min Zhang, Liver Diseases Center, The Second Xiangya Hospital, Changsha, 410011 ChinaYan Zhong, Liver Diseases Center, The Second Xiangya Hospital, Changsha, 410011 ChinaJun Chen, Liver Diseases Center, The Second Xiangya Hospital, Changsha, 410011 China
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538854</comments>
            <pubDate>Tue, 20 Dec 2011 16:44:30 +0100</pubDate>
            <guid isPermaLink="false">5538854</guid>        </item>
        <item>
            <title>Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study</title>
            <link>http://www.medworm.com/index.php?rid=5516103&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft953339313x75570%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This is the first population-based epidemiological study of PBC conducted in New Zealand and only the second in the Southern
 Hemisphere. The incidence and prevalence are lower than the Northern Hemisphere, even though the majority of our population
 has shared genetic background with some of these countries. Our study has provided further support to the hypothesis that
 there may be a protective effect or lack of a risk factor for PBC in New Zealand.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-5DOI 10.1007/s12072-011-9329-0Authors
		Jing Hieng Ngu, Department of Gastroenterology, Christchurch Hospital, Private bag 4710, Christchurch, Canterbury, New ZealandRichard Blair Gearry, Department of Gastroenterology, Christchurch Hospital, Private ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516103</comments>
            <pubDate>Wed, 14 Dec 2011 16:43:15 +0100</pubDate>
            <guid isPermaLink="false">5516103</guid>        </item>
        <item>
            <title>Complete spectrum of AMA-M2 positive liver disease in north India</title>
            <link>http://www.medworm.com/index.php?rid=5495601&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd11q16t0114hq61q%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This 13.5-year study demonstrates a definite rising annual incidence of AMA-M2-positive liver disease in north India. Complete
 evaluation of 50 patients indicated that a hepatitic variant of PBC (PBC-AIH), which is significantly associated with DRB1*03,
 predominates in north India.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s12072-011-9326-3Authors
		Ranjana W. Minz, Department of Immunopathology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 IndiaNavchetan Kaur, Department of Immunopathology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 IndiaShashi Anand, Department of Immunopathology, Post Graduate Institute of Medical Education and Research (...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495601</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:58 +0100</pubDate>
            <guid isPermaLink="false">5495601</guid>        </item>
        <item>
            <title>Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=5495602&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr73274u373500107%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;AIAG, a simple marker panel consisting of conventional parameters, could easily predict significant fibrosis with a high degree
 of accuracy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s12072-011-9328-1Authors
		Sheng-di Wu, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032 People’s Republic of ChinaYan-jun Ni, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032 People’s Republic of ChinaLi–li Liu, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032 People’s Republic of ChinaHai ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495602</comments>
            <pubDate>Fri, 09 Dec 2011 17:08:15 +0100</pubDate>
            <guid isPermaLink="false">5495602</guid>        </item>
        <item>
            <title>IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?</title>
            <link>http://www.medworm.com/index.php?rid=5488031&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff800746ql1210164%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in the core sequence of the HCV genome have been reported to influence treatment response, fibrosis progression,
 and hepatocarcinogenesis in Asian patients with genotype-1 chronic hepatitis C (CHC). In this issue, Miura et al. report data
 consistent with a causal relationship between the R70&amp;nbsp;→&amp;nbsp;Q70 core variant and hepatocellular carcinoma (HCC) risk in CHC genotype-1b
 patients, by the prospective evaluation of changes in the consensus sequence in the entire open reading frame between treatment
 failure and HCC development or end of follow-up, and validation of the initial findings in a confirmatory cohort. Furthermore,
 they observed an association between the IL28B genotype, which is believed to influence the immune response to viral infection,...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488031</comments>
            <pubDate>Tue, 06 Dec 2011 17:04:23 +0100</pubDate>
            <guid isPermaLink="false">5488031</guid>        </item>
        <item>
            <title>Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=5477506&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw1356q67lq807173%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Core immune-escape mutations cT12S, cS21T, cT67P, cE113D, and cP130T/Q are significantly higher in decompensated liver disease
 patients and could influence the severity of liver disease in HBeAg −ve CHB patients.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s12072-011-9316-5Authors
		Ranjit Chauhan, Department of Gastroenterology and Advanced Centre for Liver Diseases, G.B. Pant Hospital, Room No. 201, New Delhi, 110002 IndiaShiv K. Sarin, Department of Gastroenterology and Advanced Centre for Liver Diseases, G.B. Pant Hospital, Room No. 201, New Delhi, 110002 IndiaManoj Kumar, Department of Gastroenterology and Advanced Centre for Liver Diseases, G.B. Pant Hospital, Room No. 201, New Delhi, 110002 IndiaJayashree Bhattacharjee...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477506</comments>
            <pubDate>Thu, 01 Dec 2011 19:21:32 +0100</pubDate>
            <guid isPermaLink="false">5477506</guid>        </item>
        <item>
            <title>Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature</title>
            <link>http://www.medworm.com/index.php?rid=5469919&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnhw11335r3675434%2F</link>
            <description>In conclusion, the reviewed
 studies uniformly support the feasibility and safety of TIPS for PVT even in the presence of portal cavernoma. Further, several
 major issues that remain unresolved are discussed.
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-15DOI 10.1007/s12072-011-9324-5Authors
		Xingshun Qi, Fourth Military Medical University, Xijing Hospital of Digestive Diseases, 15 West Changle Road, Xi’an, 710032 ChinaGuohong Han, Fourth Military Medical University, Xijing Hospital of Digestive Diseases, 15 West Changle Road, Xi’an, 710032 China
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469919</comments>
            <pubDate>Wed, 30 Nov 2011 18:52:15 +0100</pubDate>
            <guid isPermaLink="false">5469919</guid>        </item>
        <item>
            <title>Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study</title>
            <link>http://www.medworm.com/index.php?rid=5469921&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr218632k36848864%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;High proportion of patients with HCC in Mongolia is diagnosed at an advanced stage and survival of these patients is lower
 compared to other countries. A surveillance system and referral policy for high-risk groups should be urgently established
 and implemented in Mongolia.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s12072-011-9325-4Authors
		Oidov Baatarkhuu, Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, 120-752 Seoul, South KoreaDo Young Kim, Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, 120-752 Seoul, South KoreaPagbajabyn Nymadawa, Mongolian Academy of Medical Science, Ulaanbaatar, MongoliaSeung Up Kim, Departme...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469921</comments>
            <pubDate>Wed, 30 Nov 2011 04:38:32 +0100</pubDate>
            <guid isPermaLink="false">5469921</guid>        </item>
        <item>
            <title>Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infection</title>
            <link>http://www.medworm.com/index.php?rid=5469920&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F27w3651382x35p00%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;More than 170 million people worldwide are infected with hepatitis C virus (HCV). A characteristic of this virus is a high
 tendency toward chronic infection. Several factors affect the viral outcome after infection. Among them, HCV-specific CD4
 T cells are thought to play a crucial role in controlling viremia. Cumulative data showed that spontaneously resolved individuals
 have vigorous CD4 T-cell responses to a broad spectrum of HCV antigens and maintain these responses over a long period of
 time, whereas chronically infected patients lose their CD4 T-cell responses in the acute phase of infection. Although several
 possibilities of why CD4 T cells lose their function have been proposed, the mechanisms are not completely understood. Moreover,
 there is another subse...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469920</comments>
            <pubDate>Wed, 30 Nov 2011 04:38:32 +0100</pubDate>
            <guid isPermaLink="false">5469920</guid>        </item>
        <item>
            <title>Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis</title>
            <link>http://www.medworm.com/index.php?rid=5469922&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9756841202975329%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;TACE provides survival benefit for metastatic HCC patients. Prospective randomized controlled trials are warranted to delineate
 the role of combining TACE with sorafenib or other treatment for metastatic HCC.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s12072-011-9322-7Authors
		I-Cheng Lee, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 112 TaiwanTeh-Ia Huo, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 112 TaiwanYi-Hsiang Huang, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 112 TaiwanYee Chao, Cance...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5469922</comments>
            <pubDate>Wed, 30 Nov 2011 04:38:31 +0100</pubDate>
            <guid isPermaLink="false">5469922</guid>        </item>
        <item>
            <title>Hepatic angiogenesis and fibrosis are common features in morbidly obese patients</title>
            <link>http://www.medworm.com/index.php?rid=5459044&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F613143746675m5x7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In severely obese patients, fibrosis is probably promoted by mechanisms independent of NASH. In these patients, angiogenesis
 is activated early in the natural history of NAFLD and correlates with the severity of fibrosis.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s12072-011-9320-9Authors
		Monika Ciupińska-Kajor, Department of Pathomorphology, Medical University of Silesia, Katowice, PolandMarek Hartleb, Department of Gastroenterology and Hepatology, Medical University of Silesia, ul. Medyków 14, 40-752 Katowice, PolandMaciej Kajor, Department of Pathomorphology, Medical University of Silesia, Katowice, PolandMichał Kukla, Department of Pathophysiology, Medical University of Silesia, Zabrze, PolandMariusz Wyleżoł, Departm...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5459044</comments>
            <pubDate>Mon, 28 Nov 2011 16:50:28 +0100</pubDate>
            <guid isPermaLink="false">5459044</guid>        </item>
        <item>
            <title>Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patients</title>
            <link>http://www.medworm.com/index.php?rid=5450127&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F144104v002118880%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;HBeAg-negative genotype D-naive patients treated with PEG-IFN α-2a achieved SVR in 23 (HBV &amp;lt;400 copies&amp;nbsp;ml−1) and 57% (HBV &amp;lt;20,000 copies&amp;nbsp;ml−1) of patients, a better response than previously reported that might be related to the absence of drug resistance in these
 naive patients. Pretreatment predictors of SVR were low body weight, high ALT, low HBV DNA, and low triglycerides.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s12072-011-9319-2Authors
		Hamad I. Al-Ashgar, Section of Gastroenterology, Department of Medicine (MBC-46), King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh, 11211 Saudi ArabiaMohammed Q. Khan, Section of Gastroenterology, Department of Medicine (MBC-46), King Faisal...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450127</comments>
            <pubDate>Thu, 24 Nov 2011 17:43:40 +0100</pubDate>
            <guid isPermaLink="false">5450127</guid>        </item>
        <item>
            <title>Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion</title>
            <link>http://www.medworm.com/index.php?rid=5349192&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbq26742756143072%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Primary LT for HCC with microvascular invasion and within the up-to-7 criteria doubled the chance of cure as compared with
 LR.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s12072-011-9318-3Authors
		See Ching Chan, State Key Laboratory for Liver Research, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaSheung Tat Fan, State Key Laboratory for Liver Research, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaKenneth S. H. Chok, Department of Surgery, The University of Hong Kong, Hong Kong, ChinaTan To Cheung, Department of Surgery, The University of Hong Kong, Hong Kong, ChinaAlbert C. Y. Chan, Department of Surgery, The University of Hong Kong, Hong Kong, ChinaJames Y. Y. Fung, Department of Medicin...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349192</comments>
            <pubDate>Fri, 21 Oct 2011 05:47:24 +0100</pubDate>
            <guid isPermaLink="false">5349192</guid>        </item>
        <item>
            <title>Risk of stroke following diagnosis with pyogenic liver abscess: a nationwide population-based study</title>
            <link>http://www.medworm.com/index.php?rid=5349193&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa79541m36100n858%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We suggest a need for more intensive medical monitoring following PLA infection, especially during the first few months. However,
 data regarding smoking were unavailable in our dataset and may have biased our findings.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s12072-011-9317-4Authors
		Joseph J. Keller, School of Medical Laboratory Sciences and Biotechnology, Taipei Medical University, Taipei, TaiwanJiunn-Horng Kang, Department of Physical Medicine and Rehabilitation, Taipei Medical University Hospital, Taipei, TaiwanJau-Jiuan Sheu, Department of Neurology, Taipei Medical University Hospital, Taipei, TaiwanHerng-Ching Lin, School of Health Care Administration, College of Medicine, Taipei Medical University, 250 Wu-Hsing St, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349193</comments>
            <pubDate>Thu, 20 Oct 2011 15:47:52 +0100</pubDate>
            <guid isPermaLink="false">5349193</guid>        </item>
        <item>
            <title>Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=5316485&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu22221225l0783r5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;LDT&amp;nbsp;+&amp;nbsp;ADV combination treatment showed better outcomes against lamivudine resistant HBV than ADV alone, with a similar safety
 profile.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s12072-011-9314-7Authors
		Sang-Hoon Ahn, Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seoul, South KoreaYoung-Oh Kweon, The Kyungpook National University Hospital, Daegu, KoreaSeung-Woon Paik, Department of Medicine/Gastroenterology, Samsung Medical Centre, Seoul, KoreaJoo-Hyun Sohn, Division of Gastroenterology, Hanyang University Guri Hospital, Gyeonggi-do, Suwon, KoreaKwan-Sik Lee, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, KoreaDong Joon Kim, Hallym University Sacr...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316485</comments>
            <pubDate>Wed, 12 Oct 2011 05:50:26 +0100</pubDate>
            <guid isPermaLink="false">5316485</guid>        </item>
        <item>
            <title>Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients</title>
            <link>http://www.medworm.com/index.php?rid=5286849&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpn4r118802883753%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Platelet count after splenectomy in cirrhotic patients can be predicted on the basis of preoperative clinical characteristics.
 When selecting patients for splenectomy, spleen weight, preoperative platelet count, and lymphocyte count should be taken
 into consideration.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-5DOI 10.1007/s12072-011-9315-6Authors
		Daisuke Yoshida, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanYoshihiro Nagao, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanMorimasa Tomikawa, Department of Advanced Medicine and Innovative Technology, Kyushu University Hospital, Fukuoka, JapanHirofumi Kawanaka, Department of...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286849</comments>
            <pubDate>Fri, 30 Sep 2011 06:21:33 +0100</pubDate>
            <guid isPermaLink="false">5286849</guid>        </item>
        <item>
            <title>Morphological and biomechanical remodelling of the hepatic artery in a swine model of portal hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5251641&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx26j22xk10718831%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The study suggests that the morphological and biomechanical properties of swine hepatic arteries have changed significantly
 during the process of portal hypertension and that from biomechanical aspects, the hepatic arteries have also suffered from
 extensive remodelling, which in turn deteriorates the existing portal hypertension.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s12072-011-9302-yAuthors
		Xi-Ju He, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaMing-Hua Yu, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaWen-Chun Li, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaHan-Qin Wang, Institute of Basic Medical Sciences, Hubei ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5251641</comments>
            <pubDate>Fri, 23 Sep 2011 05:44:11 +0100</pubDate>
            <guid isPermaLink="false">5251641</guid>        </item>
        <item>
            <title>Characteristics of autoimmune hepatitis in the Asia-Pacific Region: historical review</title>
            <link>http://www.medworm.com/index.php?rid=5239201&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj0xp228026283408%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In the era of genome-wide association studies, further progress of studies on AIH, a typical disease model for immunological
 liver cell damage, is expected.
 
 
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-8DOI 10.1007/s12072-011-9313-8Authors
		Mikio Zeniya, The Jikei University Graduate School of Medicine Gastroenterology, Tokyo, JapanHiroki Takahashi, The Jikei University Graduate School of Medicine Gastroenterology, Tokyo, Japan
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239201</comments>
            <pubDate>Sat, 17 Sep 2011 17:06:46 +0100</pubDate>
            <guid isPermaLink="false">5239201</guid>        </item>
        <item>
            <title>Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score</title>
            <link>http://www.medworm.com/index.php?rid=5210293&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl584071002064666%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The analysis using PS indicated that RBV adherence in the older patients decreased even if they did not have lower pretreatment
 RBC and Hgb levels.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s12072-011-9312-9Authors
		Hirotoshi Ebinuma, Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 JapanHidetsugu Saito, Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 JapanShinichiro Tada, Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, S...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5210293</comments>
            <pubDate>Fri, 09 Sep 2011 16:46:47 +0100</pubDate>
            <guid isPermaLink="false">5210293</guid>        </item>
        <item>
            <title>Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5197106&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx388702703l538rn%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s12072-011-9311-xAuthors
		Sunil Taneja, Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaYogesh Chawla, Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaRadha K. Dhiman, Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197106</comments>
            <pubDate>Sat, 03 Sep 2011 06:39:47 +0100</pubDate>
            <guid isPermaLink="false">5197106</guid>        </item>
        <item>
            <title>Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5185058&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmv82724727775167%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;CTHA/CTAP may be useful for detecting additional nodules prior to percutaneous ablation in patients with multinodular HCC
 on dynamic CT, in recurrent cases, and in hepatitis B surface antigen-negative cases.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s12072-011-9310-yAuthors
		Takamasa Ohki, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanRyosuke Tateishi, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanMasaaki Akahane, Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanShuichiro Shiina, Department of Gastroenterology, Gradua...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185058</comments>
            <pubDate>Tue, 30 Aug 2011 15:59:32 +0100</pubDate>
            <guid isPermaLink="false">5185058</guid>        </item>
        <item>
            <title>Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients</title>
            <link>http://www.medworm.com/index.php?rid=5163710&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56181wt236780127%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study suggests that the acetylator status of TB patients can be detected by phenotypic method as efficaciously as by
 genotypic method. Therefore, phenotypic method can replace genotypic method to determine acetylating status as phenotypic
 method is simple and inexpensive.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s12072-011-9309-4Authors
		S. V. Rana, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaR. P. Ola, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaSanjeev K. Sharma, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaS. K. Arora, Department o...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163710</comments>
            <pubDate>Wed, 24 Aug 2011 16:03:20 +0100</pubDate>
            <guid isPermaLink="false">5163710</guid>        </item>
        <item>
            <title>Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment</title>
            <link>http://www.medworm.com/index.php?rid=5163711&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg11537614401g534%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The results indicated that treatment with PEG-IFN alfa-2a plus ribavirin can achieve a complete clinical response in patients
 with HCV-related MC. Complete clinical response correlates with the eradication of HCV.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s12072-011-9303-xAuthors
		Hisham R. El Khayat, Department of Gastroenterology, Theodore Bilharz Institute, Cairo, EgyptYasser M. Fouad, Department of Tropical Medicine, Minia University, Minia, EgyptEzzat Ali Ahmad, Department of Internal Medicine, Alexandria University, Alexandria, EgyptHussein El Amin, Department of Internal Medicine, Assiut University, Assiut, EgyptFaten Ismael, Department Rheumatology, Minia University, Minia, EgyptAmal Rizk, Department Rheumatology, Cai...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163711</comments>
            <pubDate>Fri, 19 Aug 2011 06:40:07 +0100</pubDate>
            <guid isPermaLink="false">5163711</guid>        </item>
        <item>
            <title>Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=5163712&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F425v38376544377p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Taiwanese CHC patients with rs8099917 TT genotype had a higher incidence of TAs. The development of TAs and TD did not impact
 the treatment efficacy of PegIFN/RBV combination therapy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s12072-011-9308-5Authors
		Jee-Fu Huang, Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanChao-Kuan Huang, Department of Occupational and Environmental Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanMing-Lung Yu, Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanChia-Yen Dai, Hepatobiliary Division, Department of Internal ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163712</comments>
            <pubDate>Thu, 18 Aug 2011 05:47:59 +0100</pubDate>
            <guid isPermaLink="false">5163712</guid>        </item>
        <item>
            <title>Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients</title>
            <link>http://www.medworm.com/index.php?rid=5163713&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft2j04514578q4h01%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;PI-resistance-associated NS3 mutations exist in a substantial proportion of untreated HCV-1b-infected patients. The impact
 of these mutations in the treatment of PIs is unclear, but clinicians should pay attention to avoid further development of
 PI resistance.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s12072-011-9306-7Authors
		Hiroko Shindo, First Department of Internal Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanShinya Maekawa, First Department of Internal Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanKazuki Komase, First Department of Internal Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanRyota Sueki, First Dep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163713</comments>
            <pubDate>Thu, 18 Aug 2011 05:47:58 +0100</pubDate>
            <guid isPermaLink="false">5163713</guid>        </item>
        <item>
            <title>Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=5163714&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff87630ll50455567%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Hepatitis C virus core a.a. 70 residue is associated with liver disease progression and is independent factor for HCC development
 in genotype-1b infection. IL28B SNPs are related to core a.a. 70 residue, but not to HCC. The functional relevance of core
 a.a. 70 residue in hepatitis C pathogenesis should be further investigated.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s12072-011-9307-6Authors
		Mika Miura, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi, 409-3898 JapanShinya Maekawa, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi, 409-3898 JapanMakoto Kadokura, First Department of Inte...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163714</comments>
            <pubDate>Wed, 17 Aug 2011 05:56:03 +0100</pubDate>
            <guid isPermaLink="false">5163714</guid>        </item>
        <item>
            <title>Non-alcoholic fatty liver disease: is iron relevant?</title>
            <link>http://www.medworm.com/index.php?rid=5133047&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu0217uj974j62771%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Non-alcoholic fatty liver disease (NAFLD) is a common and ubiquitous disorder (Bedogni et al. in Hepatology 42:44–52, 2005;
 Bellentani et al. in Ann Intern Med 132:112–117, 2000) which in a proportion of subjects leads to non-alcoholic steatohepatitis
 (NASH), advanced liver disease and hepatocellular carcinoma. Although the factors responsible for progression of disease are
 still uncertain, there is evidence that insulin resistance (IR) is a key operative mechanism (Angulo et al. in Hepatology
 30:1356–1362, 1999) and that two stages are involved. The first is the accumulation of triglycerides in hepatocytes followed
 by a “second hit” which promotes cellular oxidative stress. Several factors may be responsible for the induction of oxidative
 stress but hep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5133047</comments>
            <pubDate>Fri, 12 Aug 2011 06:18:34 +0100</pubDate>
            <guid isPermaLink="false">5133047</guid>        </item>
        <item>
            <title>Prevention of post liver transplant HBV recurrence</title>
            <link>http://www.medworm.com/index.php?rid=5120648&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg38w375828j06607%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp; Thus, 20&amp;nbsp;years afterward, HBV recurrence is &amp;lt;5% and outcomes following liver transplantation are excellent.
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9293-8Authors
		Geoffrey W. McCaughan, The AW Morrow Gastroenterology and Liver Centre, The Centenary Research Institute, Royal Prince Alfred Hospital and The University of Sydney, Missenden Road, Camperdown, NSW 2050, Australia
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120648</comments>
            <pubDate>Wed, 10 Aug 2011 15:48:57 +0100</pubDate>
            <guid isPermaLink="false">5120648</guid>        </item>
        <item>
            <title>Effects of mutation number in interferon sensitivity determining region on peripheral blood CD4+ T cell subsets (Th1, Th2) in chronic hepatitis C patients with hepatitis C virus genotype 1b and high viral load</title>
            <link>http://www.medworm.com/index.php?rid=5110695&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv4019684312x5871%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The number of AA mutations in the ISDR influenced PB Th2 cells before and until day 28, and was associated with higher RVR
 and EVR rates.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9305-8Authors
		Koji Ishii, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Toho University School of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo, 143-8541 JapanMie Shinohara, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Toho University School of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo, 143-8541 JapanMichio Kogame, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Toho University School of Medicine, 6-11-1, Omo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110695</comments>
            <pubDate>Fri, 05 Aug 2011 06:02:34 +0100</pubDate>
            <guid isPermaLink="false">5110695</guid>        </item>
        <item>
            <title>Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis</title>
            <link>http://www.medworm.com/index.php?rid=5110694&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F52t343u145126842%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Hepatocyte growth factor ameliorated liver inflammation and fibrosis in a murine model of NASH as a result of the anti-oxidative
 and anti-apoptotic effect, and the induction of fibrinolysis.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s12072-011-9301-zAuthors
		Hiroki Tojima, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JapanSatoru Kakizaki, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JapanTakashi Kosone, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JapanNorio Horiguchi, Department of Medicine and Molecular Science, Gunma University Gra...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110694</comments>
            <pubDate>Fri, 05 Aug 2011 06:02:34 +0100</pubDate>
            <guid isPermaLink="false">5110694</guid>        </item>
        <item>
            <title>Hepatitis C virus and lipid profiles: more questions than answers?</title>
            <link>http://www.medworm.com/index.php?rid=5089227&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9112117r787l1136%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s12072-011-9298-3Authors
		Ching-Sheng Hsu, Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei, TaiwanJia-Horng Kao, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, 10002 Taiwan
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5089227</comments>
            <pubDate>Thu, 28 Jul 2011 15:56:38 +0100</pubDate>
            <guid isPermaLink="false">5089227</guid>        </item>
        <item>
            <title>Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block</title>
            <link>http://www.medworm.com/index.php?rid=5064429&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2823478082785434%2F</link>
            <description>Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9300-0Authors
		C. Busletta, Department of Experimental Medicine and Oncology, InterUniversity Center for Hepatic Pathophysiology, University of Torino, Corso Raffaello 30, 10125 Turin, ItalyE. Novo, Department of Experimental Medicine and Oncology, InterUniversity Center for Hepatic Pathophysiology, University of Torino, Corso Raffaello 30, 10125 Turin, ItalyM. Parola, Department of Experimental Medicine and Oncology, InterUniversity Center for Hepatic Pathophysiology, University of Torino, Corso Raffaello 30, 10125 Turin, Italy
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064429</comments>
            <pubDate>Fri, 22 Jul 2011 17:04:49 +0100</pubDate>
            <guid isPermaLink="false">5064429</guid>        </item>
        <item>
            <title>Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission</title>
            <link>http://www.medworm.com/index.php?rid=5064430&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F577j4220830u08pw%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The results indicate that lower baseline serum HBV-DNA level and viral load reduction over time are associated with long-term
 biochemical remission in HBeAg-negative hepatitis B carriers.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9297-4Authors
		Chih-Lin Lin, Department of Gastroenterology, Taipei City Hospital, Ren-Ai branch, Taipei, TaiwanTai-Chung Tseng, Division of Hepatogastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, TaiwanTung-Hung Su, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanChun-Jen Liu, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanPei-Jer Chen, Department of Internal Medicine, National Taiw...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064430</comments>
            <pubDate>Thu, 21 Jul 2011 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5064430</guid>        </item>
        <item>
            <title>A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol</title>
            <link>http://www.medworm.com/index.php?rid=5064431&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2037228772310281%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Adefovir dipivoxil plus bicyclol combination therapy is a safe and superior treatment regimen for patients with HBeAg-positive
 CHB when compared with ADV monotherapy.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9294-7Authors
		Wen Xie, Liver Center, Beijing Ditan Hospital, Capital Medical University, 100015 Beijing, ChinaGuangfeng Shi, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, ChinaHongfei Zhang, Department of Pediatric Hepatology, The 302 Hospital of PLA, Beijing, ChinaGuiming Zhao, Department of Hepatology, Tianjin Municipal Hospital of Infectious Diseases, Tianjin, ChinaZujiang Yu, Department of Infectious Diseases, First Hospital, Zhengzhou University, Zhengzhou, ChinaZhenwei Lang, Liver Center, Beij...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064431</comments>
            <pubDate>Tue, 19 Jul 2011 23:22:58 +0100</pubDate>
            <guid isPermaLink="false">5064431</guid>        </item>
        <item>
            <title>Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=5064432&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4g48112287qg2637%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings indicate that undetectable serum IL-6 level at the early stage of AE correlated with the long-term outcomes and
 may serve as a useful clinical predictor.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9299-2Authors
		Corinna Jen-Hui Pan, Melbourne University, Melbourne, AustraliaHui-Lin Wu, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, 1 Chang-Te Street, Taipei, 10002 TaiwanStephanie Fang-Tzu Kuo, Melbourne University, Melbourne, AustraliaJia-Horng Kao, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and National Taiwan University Hospital, 1 Chang-Te Street, Taipei, 10002 TaiwanTai-Chung Tseng, Graduate Instit...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064432</comments>
            <pubDate>Tue, 19 Jul 2011 05:47:37 +0100</pubDate>
            <guid isPermaLink="false">5064432</guid>        </item>
        <item>
            <title>Current management and recommendations on hepatitis B therapy in HIV-coinfected patients</title>
            <link>http://www.medworm.com/index.php?rid=5041009&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd00203535581243v%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Even though global management of HBV–HIV coinfected patients is improving, baseline evaluation of CHB though necessary is
 still often insufficient. The strong rationale for early dual anti-HIV and anti-HBV therapy, and the reality of everyday clinical
 practice, bring support to the recent simplification of the recommendations widening the use of tenofovir and emtricitabine
 in HBV–HIV coinfected patients, irrespective of immunological, virological, or histological considerations.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9292-9Authors
		Lionel Piroth, Département d’ Infectiologie, CHU Dijon and Université de Bourgogne, 10 boulevard du Maréchal de Lattre de Tassigny, 21079 Dijon Cedex, FranceSophie Mahy, Département d’ Infectiol...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041009</comments>
            <pubDate>Thu, 14 Jul 2011 16:55:46 +0100</pubDate>
            <guid isPermaLink="false">5041009</guid>        </item>
        <item>
            <title>Comparison of noninvasive models of fibrosis in chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=5031424&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcn7716620nu15100%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Serum fibrosis models are predictive of fibrosis in CHB and assist in identifying subjects with low–normal ALT levels for
 treatment.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s12072-011-9296-5Authors
		S. C. Raftopoulos, Department of Gastroenterology, Sir Charles Gairdner Hospital, Perth, AustraliaJ. George, Storr Liver Unit, Westmead Millenium Institute, Westmead Hospital, University of Sydney, Sydney, AustraliaM. Bourliere, Service d’Hépato-Gastroentérologie, Hôpital Saint Joseph, Marseille, FranceE. Rossi, Department of Clinical Microbiology, PathWest Laboratory Medicine, Perth, AustraliaW. B. de Boer, Department of Clinical Microbiology, PathWest Laboratory Medicine, Perth, AustraliaG. P. Jeffrey, Department of Gastroenterology, Sir Char...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031424</comments>
            <pubDate>Tue, 12 Jul 2011 06:05:11 +0100</pubDate>
            <guid isPermaLink="false">5031424</guid>        </item>
        <item>
            <title>The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up</title>
            <link>http://www.medworm.com/index.php?rid=5031425&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd016687158142335%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The rate of LAM resistance in RTRs is similar to immunocompetent CHB patients in a 2-year therapy. By roadmap concept, RTRs
 with IAVR require a change in therapy to prevent viral resistance. Relapse after LAM withdrawal is frequent. Long-term antiviral
 therapy is crucial for immunosuppressed patients.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9295-6Authors
		Tsung-Hui Hu, Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta Pei Road, Niao Sung District, Kaohsiung, 833 TaiwanMing-Chao Tsai, Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031425</comments>
            <pubDate>Mon, 11 Jul 2011 05:35:08 +0100</pubDate>
            <guid isPermaLink="false">5031425</guid>        </item>
        <item>
            <title>Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=5021857&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq64134510433v424%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Relative to other lipoproteins, low serum Apo C-III levels are the most strongly associated with chronic versus cleared infection
 and decline with increasing severity of hepatic fibrosis. Apo C-III deserves further attention as a possible marker of HCV
 disease progression.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9291-xAuthors
		J. Rowell, Division of Endocrinology, Department of Medicine, Metabolism and Nutrition, Duke University, Durham, NC, USAA. J. Thompson, Department of GI/Hepatology Research Program, Duke Clinical Research Institute, Duke University, PO Box 17969, Durham, NC 27715, USAJ. R. Guyton, Division of Endocrinology, Department of Medicine, Metabolism and Nutrition, Duke University, Durham, NC, USAX. Q. Lao, Institute for ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5021857</comments>
            <pubDate>Thu, 07 Jul 2011 05:46:03 +0100</pubDate>
            <guid isPermaLink="false">5021857</guid>        </item>
        <item>
            <title>Impact of hepatic clearance of endotoxin using endotoxin activity assay</title>
            <link>http://www.medworm.com/index.php?rid=5010663&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9736473471077w20%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The EAA is considered to be superior to the LAL method for the detection of Et, even in low endotoxinemia, and is also capable
 of elucidating the Et kinetics by accurately reflecting hepatic clearance.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s12072-011-9289-4Authors
		Yukihiro Sanada, Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi 329-0498, JapanKoichi Mizuta, Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi 329-0498, JapanTaizen Urahashi, Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke City, Tochigi 329-0498, JapanYoshiyuki Ihara, Department of Transplant Surgery, Jichi Medical University, 3311-1 Ya...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5010663</comments>
            <pubDate>Wed, 06 Jul 2011 06:34:47 +0100</pubDate>
            <guid isPermaLink="false">5010663</guid>        </item>
        <item>
            <title>Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5010664&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh86m430kj5q74676%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The recurrence rate of combination therapy was considerably high. Regardless of the therapy used, careful post-RFA follow-up
 is needed, especially if additional treatment is required after the first session or if the main lesion is ≥2&amp;nbsp;cm at the time
 of RFA.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9290-yAuthors
		Jeong Han Kim, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Gojan-dong, Danwon-gu, Ansan-si, Gyeonggi-do, 425-707 KoreaHyung Joon Yim, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Gojan-dong, Danwon-gu, Ansan-si, Gyeo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5010664</comments>
            <pubDate>Mon, 04 Jul 2011 16:17:27 +0100</pubDate>
            <guid isPermaLink="false">5010664</guid>        </item>
        <item>
            <title>The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality</title>
            <link>http://www.medworm.com/index.php?rid=4987071&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa647947428qu4tt4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In a country with a single transplant center and organ retrieval organization, the addition of MELD score to current minimal
 listing criteria does not improve prioritization of patients on the waiting list or predict posttransplant survival. Also,
 adjusting MELD score for HCC would unfairly disadvantage patients listed without HCC.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9287-6Authors
		Mohammad A. B. Al-Freah, The New Zealand Liver Transpalnt Unit, Auckland City Hospital, Private Bag 92024, Auckland 1142, Auckland, New ZealandEdward J. Gane, The New Zealand Liver Transpalnt Unit, Auckland City Hospital, Private Bag 92024, Auckland 1142, Auckland, New ZealandVicki Livingstone, Department of Community Medicine, University of Otago, Dunedi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987071</comments>
            <pubDate>Wed, 29 Jun 2011 15:50:48 +0100</pubDate>
            <guid isPermaLink="false">4987071</guid>        </item>
        <item>
            <title>Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension</title>
            <link>http://www.medworm.com/index.php?rid=4987072&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn196x14u64g14838%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Delayed periportal enhancement on the sonograms based on perflubutane microbubble agent may be a characteristic of IPH.
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s12072-011-9285-8Authors
		Hitoshi Maruyama, Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuou-ku, Chiba, 260-8670 JapanTaro Shimada, Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuou-ku, Chiba, 260-8670 JapanHiroyuki Ishibashi, Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuou-ku, Chiba, 260-8670 JapanMasanori Takahashi, Department of Medicine and Clinical Oncology, Chiba University Graduate School of Med...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987072</comments>
            <pubDate>Tue, 28 Jun 2011 06:05:05 +0100</pubDate>
            <guid isPermaLink="false">4987072</guid>        </item>
        <item>
            <title>Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice</title>
            <link>http://www.medworm.com/index.php?rid=4971230&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv430613744021l4p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In C57BL/6J mice, MHV68 infection promotes fatty liver formation and hepatic insulin resistance, which can be ameliorated
 by sirolimus.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s12072-011-9283-xAuthors
		Lei Zhao, Centre for Lipid Research, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaYa-Xi Chen, Centre for Lipid Research, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of ChinaZac Varghese, Lipid Research Unit, Centre for Nephrology, University College London (UCL) Medical School, Royal Free Ca...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971230</comments>
            <pubDate>Thu, 23 Jun 2011 16:13:11 +0100</pubDate>
            <guid isPermaLink="false">4971230</guid>        </item>
        <item>
            <title>Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients</title>
            <link>http://www.medworm.com/index.php?rid=4971231&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl16t03284048q856%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;HBsAg levels at baseline strongly associated with posttreatment response were not identified. Low HBsAg levels during peginterferon
 alfa-2a therapy were associated with high rates of posttreatment response. On-treatment HBsAg quantification may, therefore,
 help guide patient management in the future.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9280-0Authors
		Teerha Piratvisuth, NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, ThailandPatrick Marcellin, Service d’Hépatologie U773-CRB3, Hôpital Beaujon, University of Paris, Clichy, FranceMatei Popescu, F.Hoffmann-La Roche, Basel, SwitzerlandHans-Peter Kapprell, Abbott GmbH and Company, Wiesbaden-Delkenheim, GermanyVivien R...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971231</comments>
            <pubDate>Thu, 23 Jun 2011 16:13:10 +0100</pubDate>
            <guid isPermaLink="false">4971231</guid>        </item>
        <item>
            <title>Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection</title>
            <link>http://www.medworm.com/index.php?rid=4971232&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr530560567k86181%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Chronic HCV infection was associated with a significantly higher prevalence of CKD compared with controls, as well as significantly
 shorter renal survival. A higher baseline viral load is an independent predictor of CKD.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s12072-011-9284-9Authors
		Sanjaya Kumar Satapathy, Department of Internal Medicine, New York Medical College/Metropolitan Hospital Center, New York, 10029 USAChandra Sekhar Lingisetty, Department of Internal Medicine, New York Medical College/Metropolitan Hospital Center, New York, 10029 USASusan Williams, Department of Gastroenterology, New York Medical College/Metropolitan Hospital Center, 1901 First Avenue, New York, 10029 USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Pr...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971232</comments>
            <pubDate>Thu, 23 Jun 2011 06:12:38 +0100</pubDate>
            <guid isPermaLink="false">4971232</guid>        </item>
        <item>
            <title>The use of transient elastography in the management of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=4971233&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft2570g7451642670%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There has been increasing interest in noninvasive methods of assessing liver fibrosis over the last decade. The use of transient
 elastography in measuring liver stiffness has become the forefront of a wide range of noninvasive tools. Most of the other
 methods are based on measurements of biomarkers associated with fibrosis. There are several reasons for its wide acceptance,
 including the ease of performing a scan, the short procedure time, the results being immediately available on completion of
 the examination, and its reproducibility. For chronic hepatitis B (CHB), the cut-off values for F3 and F4 fibrosis range between
 7.5–12.0 and 11.0–13.4&amp;nbsp;kPa, respectively, although the cut-offs may be slightly lower in those with normal ALT. In addition
 to measurin...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971233</comments>
            <pubDate>Wed, 22 Jun 2011 06:09:16 +0100</pubDate>
            <guid isPermaLink="false">4971233</guid>        </item>
        <item>
            <title>Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection</title>
            <link>http://www.medworm.com/index.php?rid=4971234&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwt3503365225k50j%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp; TDF has the makings of an “ideal” first-line drug for the treatment of CHB.
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9282-yAuthors
		Wai-Kay Seto, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong KongMan-Fung Yuen, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong KongJames Fung, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong KongChing-Lung Lai, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971234</comments>
            <pubDate>Tue, 21 Jun 2011 18:01:05 +0100</pubDate>
            <guid isPermaLink="false">4971234</guid>        </item>
        <item>
            <title>Protective effects of green tea against hepatic injury induced by high-cholesterol diet in rats: histopathological analysis, oxidative DNA damage and COX-2 expression</title>
            <link>http://www.medworm.com/index.php?rid=4971235&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F280p534327727171%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Taken together, our results suggest that daily administration of green tea for at least 7&amp;nbsp;days displays some preventive properties
 as indicated by COX-2 downregulation and decreased oxidative DNA damage.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s12072-011-9275-xAuthors
		Bárbara B. de Moraes, Departamento de Biociências, Universidade Federal de São Paulo, UNIFESP, Santos, SP, BrazilGabriela Pasquini, Departamento de Biociências, Universidade Federal de São Paulo, UNIFESP, Santos, SP, BrazilOdair Aguiar, Departamento de Biociências, Universidade Federal de São Paulo, UNIFESP, Santos, SP, BrazilAndréa P. B. Gollücke, HEXALAB and Nutrition Department, Catholic University of Santos, Santos, BrazilSilvia S. M. Ihara, Departamento de Patolog...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971235</comments>
            <pubDate>Tue, 21 Jun 2011 16:41:41 +0100</pubDate>
            <guid isPermaLink="false">4971235</guid>        </item>
        <item>
            <title>Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years</title>
            <link>http://www.medworm.com/index.php?rid=4962169&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg482j2t36v022540%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp; Our study demonstrates that a with proper evaluation and careful consideration of risk factors, individuals older than 75&amp;nbsp;years
 of age can undergo this life-saving procedure with acceptable long-term survival.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s12072-011-9286-7Authors
		C. Burcin Taner, Department of Transplantation, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USARyan L. Ung, Department of Transplantation, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USABarry G. Rosser, Department of Transplantation, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USAJaime Aranda-Michel, Department of Transplantation, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
	

	
		...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4962169</comments>
            <pubDate>Sat, 18 Jun 2011 05:42:00 +0100</pubDate>
            <guid isPermaLink="false">4962169</guid>        </item>
        <item>
            <title>Intraoperative injuries during liver resection: analysis of 1,005 procedures</title>
            <link>http://www.medworm.com/index.php?rid=4947095&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnn7np335362l8p3t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Minor injuries causing no significant complications were the most frequent. However, prevention and proper management of the
 rare injuries of hepatocaval junction are essential to avoid increased mortality in major liver resections.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9281-zAuthors
		Michal Grat, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, 1A Banacha Street, 02-097 Warsaw, PolandKarolina Grzegorczyk, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, 1A Banacha Street, 02-097 Warsaw, PolandZbigniew Lewandowski, Department of Epidemiology, Medical University of Warsaw, Oczki Street, 02-007 Warsaw, PolandDamian Sujecki, Department of General, Transplant and Liver Su...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947095</comments>
            <pubDate>Tue, 14 Jun 2011 05:54:52 +0100</pubDate>
            <guid isPermaLink="false">4947095</guid>        </item>
        <item>
            <title>Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management</title>
            <link>http://www.medworm.com/index.php?rid=4947096&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe486310264726454%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy
 has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving
 intensive chemotherapy are particularly at a risk of HBV reactivation. Most patients with HBV reactivation are positive for
 hepatitis B surface antigen (HBsAg) and are, therefore, easily identified by recommended serological screening before chemotherapy.
 However, a small, but significant proportion of subjects who have apparently recovered from HBV infection as reflected by
 HBsAg negativity and hepatitis B core antibody positivity in HBV endemic areas may also experience reactivation when host
 immunity is severely ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947096</comments>
            <pubDate>Tue, 14 Jun 2011 05:54:51 +0100</pubDate>
            <guid isPermaLink="false">4947096</guid>        </item>
        <item>
            <title>Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network</title>
            <link>http://www.medworm.com/index.php?rid=4814769&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq601263198343vh7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Autoantibodies are frequently positive in NAFLD in the absence of autoimmune hepatitis and their occurrence is not associated
 with more advanced histologic features.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9277-8Authors
		Raj Vuppalanchi, Indiana University School of Medicine, Indianapolis, IN, USARobert J. Gould, Centre for Liver Disease, Virginia Mason Medical Centre, Seattle, WA, USALaura A. Wilson, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAAynur Unalp-Arida, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAOscar W. Cummings, Indiana University School of Medicine, Indianapolis, IN, USANaga Chalasani, Indiana University School of Medicine,...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4814769</comments>
            <pubDate>Tue, 10 May 2011 05:56:15 +0100</pubDate>
            <guid isPermaLink="false">4814769</guid>        </item>
        <item>
            <title>Efficacy of combined pegylated interferon and ribavirin therapy in Jewish patients of Israel suffering from chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=4806953&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6707836t86040712%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Combined pegylated interferon and ribavirin therapy was of similar or even higher efficacy in the Israeli population as compared
 to that reported by international trials in Caucasian, Hispanic, and African American populations.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9278-7Authors
		Jorge-Shmuel Delgado, Department of Gastroenterology and Hepatology, Faculty of Health Sciences, The Barzilai Medical Centre, Ben-Gurion University of the Negev, Beersheba, IsraelYael Baumfeld, Faculty of Health Sciences, Clinical Research Centre, Soroka University Medical Centre, Ben-Gurion University of the Negev, Beersheba, IsraelVictor Novack, Faculty of Health Sciences, Clinical Research Centre, Soroka University Medical Centre, Ben-Gurion University of ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4806953</comments>
            <pubDate>Sat, 07 May 2011 15:45:32 +0100</pubDate>
            <guid isPermaLink="false">4806953</guid>        </item>
        <item>
            <title>Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4783492&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F845624t0hk7k6412%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Poor responders have an increased risk of mortality due to rapid disease progression after TACE. Advanced BCLC stages may
 better predict a poor response to TACE.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s12072-011-9276-9Authors
		Ya-Ju Tsai, School of Nursing, National Yang-Ming University, Taipei, TaiwanChia-Yang Hsu, Faculty of Medicine, National Yang-Ming University, Taipei, TaiwanYi-Hsiang Huang, Institute of Clinical Medicine, National Yang-Ming University, Taipei, TaiwanChien-Wei Su, Faculty of Medicine, National Yang-Ming University, Taipei, TaiwanHan-Chieh Lin, Faculty of Medicine, National Yang-Ming University, Taipei, TaiwanRheun-Chuan Lee, Faculty of Medicine, National Yang-Ming University, Taipei, TaiwanJen-Huey Chiang, Faculty of Medic...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783492</comments>
            <pubDate>Sat, 30 Apr 2011 05:55:28 +0100</pubDate>
            <guid isPermaLink="false">4783492</guid>        </item>
        <item>
            <title>The dissociation between the diabetes and both Child–Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic</title>
            <link>http://www.medworm.com/index.php?rid=4745353&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F707871q176034l11%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The prevalence of diabetes was higher in cirrhotic patients in Taiwan. The prevalence of diabetes was dissociated with Child–Pugh
 or MELD score. The diagnosis of diabetes did not affect the renal function or in-hospital mortality in cirrhotic patients.
 Since the clinical outcomes of diabetes were different from cirrhotic patients to general population, it is unclear whether
 the treatment of diabetes and improved glycemic control will benefit cirrhotic patients.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s12072-011-9274-yAuthors
		Yu-Wei Chen, Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanHan-Hsiang Chen, Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Tai...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745353</comments>
            <pubDate>Wed, 20 Apr 2011 06:10:53 +0100</pubDate>
            <guid isPermaLink="false">4745353</guid>        </item>
        <item>
            <title>Clinical features of clinically diagnosed eosinophilic liver abscesses</title>
            <link>http://www.medworm.com/index.php?rid=4687386&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk66w137553734141%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Clinically diagnosed ELA adopts a relatively benign course. Empirical anti-parasitic treatment in patients without an identified
 etiology may shorten the duration of clinically diagnosed ELA.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9272-0Authors
		Jae-Woo Kwon, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South KoreaTae-Wan Kim, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South KoreaKyung-Mook Kim, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South KoreaSo-Hee Lee, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South KoreaSang-Heon Cho, Department of Internal Medicine, Seou...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687386</comments>
            <pubDate>Tue, 05 Apr 2011 16:58:39 +0100</pubDate>
            <guid isPermaLink="false">4687386</guid>        </item>
        <item>
            <title>Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=4687387&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn2r36p3065512068%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results suggest that viral kinetics is affected by different host factors for genotypes 1 and 2.
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9273-zAuthors
		Shunsuke Sato, Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, JapanTakuya Genda, Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, JapanKatsuharu Hirano, Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, JapanHironori Tsuzura, Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, JapanYoshio Kanemitsu, Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Shizuoka, JapanYut...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687387</comments>
            <pubDate>Sun, 03 Apr 2011 05:43:46 +0100</pubDate>
            <guid isPermaLink="false">4687387</guid>        </item>
        <item>
            <title>Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey</title>
            <link>http://www.medworm.com/index.php?rid=4665771&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc635w17m53485812%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Liver transplant patients exhibiting early deterioration of graft function or other hepatic symptoms should, in addition to
 assessment for rejection, be evaluated for H-PTLD. In addition, all H-PTLD patients should be evaluated for bone marrow involvement,
 especially if they are EBV positive. Prospective studies with large patient populations are needed to confirm our results.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9271-1Authors
		Morteza Izadi, Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IranMozhgan Fazel, International Travel Medicine Center of Iran, Tehran, IranSeyed Hasan Saadat, Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IranSaeed Taheri, Dr. Taheri Medical Researc...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4665771</comments>
            <pubDate>Tue, 29 Mar 2011 06:07:58 +0100</pubDate>
            <guid isPermaLink="false">4665771</guid>        </item>
        <item>
            <title>Acute kidney injury as a causal factor in mortality associated with hepatorenal syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4654765&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F532423643x550822%2F</link>
            <description>Abstract
 Purpose&amp;nbsp;&amp;nbsp;We examine how acute kidney injury (AKI) contributes to mortality in patients with liver failure.
 
 
 
 Content&amp;nbsp;&amp;nbsp;Hepatorenal syndrome (HRS) is a form of AKI in cirrhotic patients, which is defined as a purely physiologic derangement in
 renal function without any effect on renal parenchyma. Recent literature challenges this understanding. Little attention is
 paid to the presence of renal pathology and inflammatory alterations that occur as a result of HRS and their contribution
 to morbidity and mortality. In this paper, we propose that any type of AKI in the presence of liver disease is an inflammatory
 condition. The combination of AKI and liver failure produces a “toxic milieu” of cytokines, chemokines, and nitric oxide pathway
 metabolites t...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4654765</comments>
            <pubDate>Sun, 27 Mar 2011 05:43:34 +0100</pubDate>
            <guid isPermaLink="false">4654765</guid>        </item>
        <item>
            <title>Validation of graft and standard liver size predictions in right liver living donor liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=4645687&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Feqm88487461mh244%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;SLV and graft weight estimations were accurate using the formula and conversion factor.
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s12072-011-9264-0Authors
		See Ching Chan, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaChung Mau Lo, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaKenneth S. H. Chok, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaWilliam W. Sharr, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaTan To Cheung, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaSimon H. Y. Tsang, Department of Surgery, The University of Hong Kong, 102 Pokfulam Road,...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645687</comments>
            <pubDate>Fri, 25 Mar 2011 18:51:51 +0100</pubDate>
            <guid isPermaLink="false">4645687</guid>        </item>
        <item>
            <title>Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis</title>
            <link>http://www.medworm.com/index.php?rid=4645688&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh1612r3r3159r472%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients with high serum HBV-DNA and HBcrAg levels before OLT (particularly &amp;gt;3 log10 copies/mL and &amp;gt;4 log10 IU/mL, respectively) should be followed with care for HBV recurrence.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s12072-011-9265-zAuthors
		Tetsuya Yasunaka, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanAkinobu Takaki, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanTakahito Yagi, Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanYoshiaki Iwasaki, H...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645688</comments>
            <pubDate>Fri, 25 Mar 2011 05:51:39 +0100</pubDate>
            <guid isPermaLink="false">4645688</guid>        </item>
        <item>
            <title>Lidocaïne test for easier and less time consuming assessment of liver function in several hepatic injury models</title>
            <link>http://www.medworm.com/index.php?rid=4632808&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fww763n502056871h%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our method provides reliable and reproducible results using only a small portion of liver which allows for a fast and easy
 assessment of liver metabolic capacity. Moreover, our method presents an alternative to the in vivo technique and seems more
 feasible in a clinical setting.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9270-2Authors
		Dorra Ben Said, Service de Pharmacologie Clinique, Centre National de Pharmacovigilance, Tunis, TunisiaRidha Ben Ali, Service de Pharmacologie Clinique, Centre National de Pharmacovigilance, Tunis, TunisiaHenda Ferchichi, Service de Pharmacologie Clinique, Centre National de Pharmacovigilance, Tunis, TunisiaIssam Salouage, Service de Pharmacologie Clinique, Centre National de Pharmacovigilance, Tunis, Tunisi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4632808</comments>
            <pubDate>Wed, 23 Mar 2011 06:08:00 +0100</pubDate>
            <guid isPermaLink="false">4632808</guid>        </item>
        <item>
            <title>Is interleukin-8 an additional to histopathological changes diagnostic marker in HCV-infected patients with cryoglobulinemia?</title>
            <link>http://www.medworm.com/index.php?rid=4617401&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F574883r862n3n572%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The serum levels of all proinflammatory cytokines, especially IL-8, were significantly higher in the patients with cryoglobulinemia
 in comparison with the patients without cryoglobulinemia and healthy persons. All microscopic features did not correlate with
 the level of any investigated proinflammatory cytokines.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9268-9Authors
		Joanna Cielecka-Kuszyk, Department of Virology, National Institute of Public Health, National Institute of Hygiene, 24, Chocimska Street, 00-791 Warsaw, PolandJoanna Siennicka, Department of Virology, National Institute of Public Health, National Institute of Hygiene, 24, Chocimska Street, 00-791 Warsaw, PolandJoanna Jabłońska, Department of Hepatology and Acquired Immun...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617401</comments>
            <pubDate>Sun, 20 Mar 2011 05:32:42 +0100</pubDate>
            <guid isPermaLink="false">4617401</guid>        </item>
        <item>
            <title>Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy</title>
            <link>http://www.medworm.com/index.php?rid=4617402&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe43003w2473854t1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The outcome of PEG-IFN/RBV therapy is significantly influenced by variation in the core and NS5A regions in genotype 2a HCV
 infection.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s12072-011-9267-xAuthors
		Makoto Kadokura, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanShinya Maekawa, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanRyota Sueki, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, JapanMika Miura, First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110, Shimoka...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617402</comments>
            <pubDate>Sat, 19 Mar 2011 16:59:45 +0100</pubDate>
            <guid isPermaLink="false">4617402</guid>        </item>
        <item>
            <title>HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines</title>
            <link>http://www.medworm.com/index.php?rid=4617403&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc7g1773036k48324%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;HBV/A and HBV/C genotypes are equally predominant among Filipino patients with Chronic HBV infection seen in two specialty
 clinics in Cebu City, Philippines.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9263-1Authors
		Karen S. Batoctoy, Section of Gastroenterology, Department of Internal Medicine, Cebu Doctors’ University Hospital, Cebu City, The PhilippinesTai-Chung Tseng, Division of Hepatogastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital Taipei Branch, Taipei, TaiwanJia-Horng Kao, Division of Gastroenterology, Department of Internal Medicine, Graduate Institute of Clinical Medicine; Hepatitis Research Center, Tapei, TaiwanFidelis E. Quiza, Clinico-Epidemiology Unit, Cebu Institute of Medicine, Cebu City...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617403</comments>
            <pubDate>Sat, 19 Mar 2011 06:35:09 +0100</pubDate>
            <guid isPermaLink="false">4617403</guid>        </item>
        <item>
            <title>Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis</title>
            <link>http://www.medworm.com/index.php?rid=4596679&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6372rxt081422p82%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Serum CysC level may be considered a predictor of HRS and mortality in patients with liver cirrhosis and ascites.
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9266-yAuthors
		Mohammed A. Sharawey, Department of Internal Medicine, Faculty of Medicine, Minia University, El-Minia, EgyptEglal M. Shawky, Department of Internal Medicine, Faculty of Medicine, Minia University, El-Minia, EgyptLamia H. Ali, Department of Clinical Pathology, Faculty of Medicine, Minia University, El-Minia, EgyptAhmed Ali Mohammed, Department of Internal Medicine, Faculty of Medicine, Minia University, El-Minia, EgyptHatem A. Hassan, Department of Internal Medicine, Faculty of Medicine, Minia University, El-Minia, EgyptYasser M. Fouad, Department of Tropical Medicine, Facul...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4596679</comments>
            <pubDate>Sat, 12 Mar 2011 07:00:52 +0100</pubDate>
            <guid isPermaLink="false">4596679</guid>        </item>
        <item>
            <title>Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=4578701&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe764tl32n5h6r2g5%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SDPSC, a mild disease at presentation typically runs a benign course and likely is not an early stage of classic PSC. Further
 studies with a control group of classic PSC and longer follow-up are needed to study the natural history of SDPSC.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-011-9260-4Authors
		A. K. Singal, Department of Gastroenterology, University of Texas Medical Branch, Galveston, TX USAC. M. Stanca, Department of Liver Diseases, Mount Sinai Medical Center, New York, NY USAV. Clark, Department of Gastroenterology, Hepatology, Nutrition, University of Florida, Gainesville, FL USAL. Dixon, Department of Pathology, University of Florida, Gainesville, FL USAC. Levy, Department of Gastroenterology, Hepatology, Nutrition, University of F...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578701</comments>
            <pubDate>Thu, 10 Mar 2011 17:13:34 +0100</pubDate>
            <guid isPermaLink="false">4578701</guid>        </item>
        <item>
            <title>HBV life cycle and novel drug targets</title>
            <link>http://www.medworm.com/index.php?rid=4578702&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F574k604k1802783m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;With up to 400 million affected people worldwide, chronic hepatitis B virus (HBV) infection is still a major health care problem.
 During the last decade, several novel therapeutic approaches have been developed and evaluated. In most regions of the world,
 interferon-α, and nucleos(t)ide analogues (NUCs) are currently approved. Despite major improvements, none of the existing
 therapies is optimal since viral clearance is rarely achieved. Recently, a better understanding of the HBV life cycle and
 the development of novel model systems of HBV infection have led to the development of novel antiviral strategies and drug
 targets. This review will focus on current and potential future drug targets in the HBV life cycle and strategies to modulate
 the virus–host interac...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578702</comments>
            <pubDate>Tue, 08 Mar 2011 06:44:12 +0100</pubDate>
            <guid isPermaLink="false">4578702</guid>        </item>
        <item>
            <title>Serum retinol binding protein 4 and clinical outcome in postoperative biliary atresia</title>
            <link>http://www.medworm.com/index.php?rid=4562250&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F34p8404415q265hh%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Serum RBP4 levels decreased in BA patients compared with normal participants, and its levels declined significantly in patients
 with more severe disease. RBP4 may play a role in the pathogenesis of hepatic fibrosis and serve as a possible biomarker reflecting
 disease severity in postoperative BA patients.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9262-2Authors
		Maneerat Chayanupatkul, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330 ThailandSittisak Honsawek, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330 ThailandVoranush Chongsrisawat, Department of Pediatrics, Faculty of Medicine, Centre of Excellence in Clinical Virology, Chulalongkorn University, Bangkok...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562250</comments>
            <pubDate>Sat, 05 Mar 2011 16:51:56 +0100</pubDate>
            <guid isPermaLink="false">4562250</guid>        </item>
        <item>
            <title>Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations</title>
            <link>http://www.medworm.com/index.php?rid=4503285&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3782853x58334m79%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Management of acute variceal bleeding in Asia–Pacific region needs special attention for uniformity of treatment and future
 clinical trials.
 
 
 
 
	Content Type Journal ArticlePages 1-18DOI 10.1007/s12072-010-9236-9Authors
		Shiv Kumar Sarin, Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, IndiaAshish Kumar, Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, IndiaPeter W. Angus, Department of Gastroenterology, Austin Health, Studley Rd, Heidelberg, 3084 AustraliaSanjay Saran Baijal, Department of Radiodiagnosis, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014 IndiaSoon Koo Baik, Division of Gastroenterology and Hepatology, Department of Internal Medic...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503285</comments>
            <pubDate>Fri, 18 Feb 2011 17:24:07 +0100</pubDate>
            <guid isPermaLink="false">4503285</guid>        </item>
        <item>
            <title>Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=4503287&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9778u36783252t36%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;While MELD and sodium MELD were each significantly associated with survival after OLT, their predictive abilities were poor.
 The sodium MELD score does not improve prediction accuracy over the MELD score. Weak prediction may result from unaccounted
 variability in recipient and donor status, as well as surgical and postoperative factors.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s12072-011-9257-zAuthors
		Jacek B. Cywinski, Departments of General Anesthesiology and Outcomes Research, Transplantation Center, Cleveland Clinic, Cleveland, OH USAEdward J. Mascha, Departments of Quantitative Health Sciences and Outcomes Research, Cleveland Clinic, Cleveland, OH USAJing You, Departments of Quantitative Health Sciences and Outcomes Research, Cleveland Clinic...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503287</comments>
            <pubDate>Thu, 17 Feb 2011 08:11:25 +0100</pubDate>
            <guid isPermaLink="false">4503287</guid>        </item>
        <item>
            <title>Successful liver transplantation for Rendu–Weber–Osler disease, a single centre experience</title>
            <link>http://www.medworm.com/index.php?rid=4503286&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh64531514025g648%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Despite new advances in immunotherapy for the medical treatment of Rendu–Weber–Osler disease, liver transplantation remains
 the curative option for hepatic based-hereditary hemorrhagic telangiectasia.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9259-xAuthors
		Murat Cag, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre, Strasbourg, FranceMaxime Audet, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre, Strasbourg, FranceAnne-Catherine Saouli, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital de Hautepierre, Strasbourg, FranceMurad Odeh, Pôle des Pathologies Digestives, Hépatiques et de la Transplantation, Hôpital ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503286</comments>
            <pubDate>Thu, 17 Feb 2011 08:11:25 +0100</pubDate>
            <guid isPermaLink="false">4503286</guid>        </item>
        <item>
            <title>Risk factors for mortality in cirrhotic patients with sepsis</title>
            <link>http://www.medworm.com/index.php?rid=4484964&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv0v7v812978q0031%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Septic cirrhotic patients with pneumonia, &amp;gt;1 site of infection, Child’s C cirrhosis, and high MELD score had a high mortality
 risk.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9258-yAuthors
		Lee-Guan Lim, Department of Gastroenterology and Hepatology, National University Health System, Singapore, SingaporeXiang-Xuan Eunice Tan, National University of Singapore High School, Singapore, SingaporeShu-Jeng Woo, Department of Gastroenterology and Hepatology, National University Health System, Singapore, SingaporeYock-Young Dan, Department of Gastroenterology and Hepatology, National University Health System, Singapore, SingaporeYin-Mei Lee, Department of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4484964</comments>
            <pubDate>Mon, 14 Feb 2011 07:13:41 +0100</pubDate>
            <guid isPermaLink="false">4484964</guid>        </item>
        <item>
            <title>Protective effect of probucol on liver injury induced by carbon tetrachloride in rats</title>
            <link>http://www.medworm.com/index.php?rid=4471215&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F66n9t183t8046800%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;For the first time, we demonstrated that probucol has protective effect against liver injury in animal experiment. The antioxidant
 action of probucol may play an important role in its hepatoprotective mechanism. Probucol also can reduce serum cholesterol.
 Thus, probucol may have the potential use in clinical liver diseases in which oxidative stress may be present, especially
 for the patients with hypercholesterolemia.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9256-0Authors
		Yu-Tao Zhan, Department of Gastroenterology and Hepatology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730 People’s Republic of ChinaJing Weng, Reproductive Medicine Centre, Capital Medical University, Beijing, 100069 People’s Republic of C...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4471215</comments>
            <pubDate>Thu, 10 Feb 2011 06:55:33 +0100</pubDate>
            <guid isPermaLink="false">4471215</guid>        </item>
        <item>
            <title>Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients</title>
            <link>http://www.medworm.com/index.php?rid=4461276&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7944749104980647%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our study showed that the co-inheritance of IL-18, IFN-γ and IL-10 specific high-risk genotypes is associated with a greater
 risk for liver cirrhosis.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-010-9232-0Authors
		Nadia Bouzgarrou, Molecular Immuno-oncology Laboratory, Faculty of Medicine, Monastir, TunisiaElham Hassen, Molecular Immuno-oncology Laboratory, Faculty of Medicine, Monastir, TunisiaOlfa Bahri, Clinical Virology Laboratory, Pasteur Institute, Tunis, TunisiaSallouha Gabbouj, Molecular Immuno-oncology Laboratory, Faculty of Medicine, Monastir, TunisiaNabil Ben Mami, Gastroenterology B Unit, La Rabta Hospital, Tunis, TunisiaHenda Triki, Clinical Virology Laboratory, Pasteur Institute, Tunis, TunisiaLotfi Chouchane, Molecular Immuno-onc...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461276</comments>
            <pubDate>Mon, 07 Feb 2011 22:02:40 +0100</pubDate>
            <guid isPermaLink="false">4461276</guid>        </item>
        <item>
            <title>Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=4451796&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw4x2564262jm190t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although serum 249serine p53 mutation is rarely found in Taiwanese patients, HBV carriers have a higher prevalence of codon 72 mutants than patients
 with much severe liver diseases or HCV infection, which implies that codon 72 mutants may affect at an earlier stage of HBV
 infection. Further studies are necessary to delineate the interactions of p53 mutations with HBV infection.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-010-9248-5Authors
		Yone-Han Mah, Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanChing-Sheng Hsu, Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451796</comments>
            <pubDate>Sun, 06 Feb 2011 06:36:49 +0100</pubDate>
            <guid isPermaLink="false">4451796</guid>        </item>
        <item>
            <title>Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines</title>
            <link>http://www.medworm.com/index.php?rid=4451797&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb0321u7955v3q1l4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Developing efficient induction and culture methods to generate more highly matured hepatocytes is essential for regenerative
 cell-based therapies. Our protocol provides a simple, cost-effective, and time-saving approach for generating hepatic cells
 from iPS cells.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s12072-011-9251-5Authors
		Akemi Takata, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanMotoyuki Otsuka, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanTomomi Kogiso, Department of Medicine and Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, JapanKentaro Kojima, Department of Gastroenterology, Graduate School of Medicine, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451797</comments>
            <pubDate>Sat, 05 Feb 2011 16:56:46 +0100</pubDate>
            <guid isPermaLink="false">4451797</guid>        </item>
        <item>
            <title>Hepatitis C virus infection among patients with non-Hodgkin’s lymphoma in northern India</title>
            <link>http://www.medworm.com/index.php?rid=4430071&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdxr21nu776674585%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;HCV infection is unlikely to be associated with lymphoproliferative disorders in northern India and does not play a major
 role in the pathogenesis of lymphoproliferative disorders.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s12072-010-9244-9Authors
		Subhash Varma, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaMadhav C. Menon, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaAshish Garg, Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaPankaj Malhotra, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4430071</comments>
            <pubDate>Sat, 29 Jan 2011 17:20:19 +0100</pubDate>
            <guid isPermaLink="false">4430071</guid>        </item>
        <item>
            <title>Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate</title>
            <link>http://www.medworm.com/index.php?rid=4430072&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F780430625j64825w%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Greater RRI, abdominal obesity, and greater BLS account for a lower GFR in NAFLD patients suggesting the hypothesis that inter-related
 factors can be operating early in the natural history of obesity-related kidney and liver disease.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-011-9254-2Authors
		Daniela Catalano, Dipartimento di Medicina Interna, Istituto di Medicina Interna e Terapia Medica, Facoltà di Medicina e Chirurgia, Università di Catania, Catania, ItalyGuglielmo M. Trovato, Dipartimento di Medicina Interna, Istituto di Medicina Interna e Terapia Medica, Facoltà di Medicina e Chirurgia, Università di Catania, Catania, ItalyGiuseppe Fabio Martines, Dipartimento di Medicina Interna, Istituto di Medicina Interna e Terapia Medica, Facolt...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4430072</comments>
            <pubDate>Fri, 28 Jan 2011 06:55:27 +0100</pubDate>
            <guid isPermaLink="false">4430072</guid>        </item>
        <item>
            <title>Coffee prevents CCl4-induced liver cirrhosis in the rat</title>
            <link>http://www.medworm.com/index.php?rid=4412581&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj38t2573hl6u4276%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest (1) that coffee plays a causative role in preventing cirrhosis (at least experimental cirrhosis); (2) that action mechanisms are probably associated with down regulation of the profibrogenic cytokine TGF-β and to its antioxidant
 properties and, (3) that GC is more potent than SC. These findings suggest a beneficial effect of coffee on the liver. However, more clinical
 and basic studies must be performed before reaching a final recommendation.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-010-9247-6Authors
		Mario G. Moreno, Departamento de Farmacología, Cinvestav-IPN, Apdo. Postal 14-740, 07000 México, DF MéxicoEnrique Chávez, Departamento de Farmacología, Cinvestav-IPN, Apdo. Postal 14-740, 07000 México, DF MéxicoLise...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4412581</comments>
            <pubDate>Tue, 25 Jan 2011 06:45:43 +0100</pubDate>
            <guid isPermaLink="false">4412581</guid>        </item>
        <item>
            <title>Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation</title>
            <link>http://www.medworm.com/index.php?rid=4412582&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhq8n973832236817%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Serum HBV DNA load is associated with the risk of recurrence of HBV-related HCC after RFA.
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9255-1Authors
		Tadashi Goto, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanHaruhiko Yoshida, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanRyosuke Tateishi, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanKenichiro Enooku, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanEriko Goto, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4412582</comments>
            <pubDate>Tue, 25 Jan 2011 06:45:41 +0100</pubDate>
            <guid isPermaLink="false">4412582</guid>        </item>
        <item>
            <title>Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers</title>
            <link>http://www.medworm.com/index.php?rid=4401509&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft8552q2j64313422%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Livers from donors positive for antibody against anti-HBc can potentially transmit de novo hepatitis B (DNH) to their recipients.
 Despite a good outcome, prophylaxis is usually offered to such recipients. There is no consensus on the standard prophylactic
 regimen and hence prophylaxis varies among different transplant centres. Nonetheless, hepatitis B immune globulin (HBIG) is
 considered the mainstay of such prophylaxis, either alone or in combination with an oral antiviral treatment. We aim to provide
 a concise review of the current use of HBIG in prevention of DNH. We also address a few important questions regarding HBIG
 use.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s12072-010-9250-yAuthors
		Jen-Jung Pan, Division of Gastroenterology, Hepatology and...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401509</comments>
            <pubDate>Sat, 22 Jan 2011 07:32:41 +0100</pubDate>
            <guid isPermaLink="false">4401509</guid>        </item>
        <item>
            <title>Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4401510&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1751p2048133006%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These data suggest that sorafenib is generally tolerated in Japanese patients with HCC. Nevertheless, the majority needed
 a dose reduction. Adverse events including HFSR, rash, and liver failure occurred more frequently in our patients than those
 reported elsewhere. Careful attention must be paid to these adverse events during sorafenib administration.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-010-9249-4Authors
		Sadahisa Ogasawara, Department of Medicine and Clinical Oncology, Graduate School of Medicine, University of Chiba, 1-8-1 Inohana, Chuo-ku, 260-8670 Chiba, JapanFumihiko Kanai, Department of Medicine and Clinical Oncology, Graduate School of Medicine, University of Chiba, 1-8-1 Inohana, Chuo-ku, 260-8670 Chiba, JapanShuntaro Obi, Dep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401510</comments>
            <pubDate>Sat, 22 Jan 2011 07:32:40 +0100</pubDate>
            <guid isPermaLink="false">4401510</guid>        </item>
        <item>
            <title>Gene profiling of early and advanced liver disease in chronic hepatitis C patients</title>
            <link>http://www.medworm.com/index.php?rid=4401511&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr37n311g1q134810%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The results of this study reflect the changes taking place during the transition from early to advanced liver fibrosis, when
 the liver function becomes impaired and extracellular matrix deposition increases. In addition, it showed altered expression
 of genes with functions in cancer development, cell growth, proliferation, and cell death that might indicate high risk of
 cell transformation and hepatocellular carcinoma (HCC) in A-HCV disease patients.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-011-9252-4Authors
		Saira Sarfraz Khalid, Department of Biological and Biomedical Sciences, Aga Khan University Hospital, Juma Research Building, Stadium Road, Karachi, PakistanSaeed Hamid, Department of Medicine, Aga Khan University Hospital, Stadium Roa...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401511</comments>
            <pubDate>Sat, 22 Jan 2011 07:32:37 +0100</pubDate>
            <guid isPermaLink="false">4401511</guid>        </item>
        <item>
            <title>Non-invasive assessment of liver fibrosis in chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=4401512&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F86x027348p7k6556%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Quantification of hepatic fibrosis is of critical importance in chronic hepatitis C not only for prognosis, but also for antiviral
 treatment indication. Two end points are clinically relevant: detection of significant fibrosis (indication for antiviral
 treatment) and detection of cirrhosis (screening for eosphageal varices and hepatocellular carcinoma). Until recently, liver
 biopsy was considered the reference method for the evaluation of liver fibrosis. Limitations of liver biopsy (invasiveness,
 sampling error, and inter-observer variability) have led to the development of non-invasive methods. Currently available methods
 rely on two different approaches: a “biological” approach based on the dosage of serum fibrosis biomarkers; and a “physical”
 approach b...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401512</comments>
            <pubDate>Thu, 20 Jan 2011 07:09:27 +0100</pubDate>
            <guid isPermaLink="false">4401512</guid>        </item>
        <item>
            <title>De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients</title>
            <link>http://www.medworm.com/index.php?rid=4383813&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr12p178743885649%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Both LAM&amp;nbsp;+&amp;nbsp;ADV combination therapy and ETV monotherapy are effective in naïve HBeAg-negative CHB patients, but further studies
 are needed to obtain long-term results.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s12072-010-9243-xAuthors
		Li-Chun Wang, Centre of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, ChinaEn-Qiang Chen, Centre of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, ChinaJing Cao, Information Centre, Sichuan Provincial Hospital for Women and Children, Chengdu, ChinaLi Liu, Centre of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, ChinaLi Zheng, Centre of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, ChinaDa-Jiang Li, Centre of Inf...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383813</comments>
            <pubDate>Tue, 18 Jan 2011 19:38:20 +0100</pubDate>
            <guid isPermaLink="false">4383813</guid>        </item>
        <item>
            <title>Nonleukemic myeloid sarcoma of the liver: a case report and review of literature</title>
            <link>http://www.medworm.com/index.php?rid=4364008&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5j24829t855m7263%2F</link>
            <description>This report describes an unusual
 case of nonleukemic MS of the liver in a 16-year-old patient presenting as debilitating hepatomegaly. A liver biopsy revealed
 diffuse infiltration by neoplastic cells of myeloid lineage (CD68, myeloperoxidase). A bone marrow biopsy showed no evidence
 of medullary involvement. The patient subsequently developed heart failure. Autopsy revealed infiltration of most organs by
 neoplastic cells but failed to identify abnormal myeloid cells in bone marrow.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s12072-010-9233-zAuthors
		Xiao-Feng Hang, Department of Infectious Diseases, Changzheng Hospital, Second Military Medical University, Shanghai, 200003 ChinaHai-Guang Xin, Department of Infectious Diseases, Changzheng Hospital, Second Military Medical Uni...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4364008</comments>
            <pubDate>Sat, 15 Jan 2011 06:58:47 +0100</pubDate>
            <guid isPermaLink="false">4364008</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=4364009&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc846567066710p16%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s12072-011-9253-3

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4364009</comments>
            <pubDate>Sat, 15 Jan 2011 06:58:44 +0100</pubDate>
            <guid isPermaLink="false">4364009</guid>        </item>
        <item>
            <title>The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients</title>
            <link>http://www.medworm.com/index.php?rid=4364010&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7l6x141h7274277%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Although a statistically significant difference in patient/graft survival for HCV and non-HCV recipients of DCD organs was
 not shown, it is clear that more dire consequences exist for HCV recipients of DCD grafts, highlighting the need for larger
 data sets for evaluating this patient population
 
 
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s12072-010-9242-yAuthors
		Mohammad Mawardi, Multi-Organ Transplant Program, University Hospital, London Health Sciences Centre, 339 Windermere Road, London, ON N6A 5A5, CanadaFaisal Aba Alkhail, Multi-Organ Transplant Program, University Hospital, London Health Sciences Centre, 339 Windermere Road, London, ON N6A 5A5, CanadaKazuhiro Katada, Multi-Organ Transplant Program, University Hospital, London Health Sciences Ce...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4364010</comments>
            <pubDate>Sat, 15 Jan 2011 00:56:58 +0100</pubDate>
            <guid isPermaLink="false">4364010</guid>        </item>
        <item>
            <title>Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients</title>
            <link>http://www.medworm.com/index.php?rid=4346152&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl8212h3058168562%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The study concludes that in our population, NCPF constitutes about 5% of the subset of end stage CLD considered eligible for
 liver transplantation (LT), presenting mostly as cryptogenic cirrhosis (CC). A diagnosis of NCPF should be considered when
 patients presumed to have cryptogenic or other cirrhosis become eligible for LT even in the presence of relatively well-preserved
 liver function and low MELD scores. End stage CLD manifests at earlier age, when cirrhosis of another etiology supervenes
 on pre-existent NCPF.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-010-9246-7Authors
		Sanjiv Saigal, Department of Liver Transplant, Sir Ganga Ram Hospital, New Delhi, IndiaNabeen C. Nayak, Department of Pathology, Sir Ganga Ram Hospital, New Delhi, In...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4346152</comments>
            <pubDate>Tue, 11 Jan 2011 18:05:18 +0100</pubDate>
            <guid isPermaLink="false">4346152</guid>        </item>
        <item>
            <title>Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis</title>
            <link>http://www.medworm.com/index.php?rid=4346153&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd8717712x5r3154j%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although hyperintensity of tumor on T2-weighted imaging and arterial hypervascularity of tumor are considered to be useful
 for differential diagnosis between well differentiated HCCs and moderately/poorly differentiated HCCs, hypointensity of tumor
 on T1-weighted imaging and tumor stain washout during the portal phase of Gd-DTPA dynamic MRI reflected poorer histological
 differentiation of HCCs and correlated with AFP-L3 levels.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s12072-010-9245-8Authors
		Shotaro Enomoto, Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera Wakayama City, Wakayama, 641-0012 JapanHideyuki Tamai, Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera Wakayama City, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4346153</comments>
            <pubDate>Mon, 10 Jan 2011 15:54:09 +0100</pubDate>
            <guid isPermaLink="false">4346153</guid>        </item>
        <item>
            <title>Differential response related to genotoxicity in multiple organs of cirrhotic rats</title>
            <link>http://www.medworm.com/index.php?rid=4323154&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg41l42m30n376827%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In conclusion, our results suggest that cirrhosis could contribute to DNA damage in liver and brain cells.
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s12072-010-9239-6Authors
		Marcia R. Nagaoka, Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP BrazilLuciana Le Sueur-Maluf, Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP BrazilOdair Aguiar, Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP BrazilGlaucia M. Castro, Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP BrazilRegina C. Spadari-Bratfisch, Departamento de Biociências, Universidade Federal de Sao Paulo, UNIFESP, Santos, SP BrazilDaniel A. Ribeiro, Departam...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4323154</comments>
            <pubDate>Wed, 05 Jan 2011 16:52:35 +0100</pubDate>
            <guid isPermaLink="false">4323154</guid>        </item>
        <item>
            <title>Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance</title>
            <link>http://www.medworm.com/index.php?rid=4319497&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F84l5321435qj63v0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The combination of lamivudine and adefovir for 2&amp;nbsp;years generally proved effective in lamivudine-resistant cases, but there
 was a persistently high rate of detection of lamivudine resistant mutants and impaired virologic response in compensated patients.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9228-9Authors
		Robert P. Perrillo, Baylor University Medical Center, Dallas, TX USAHie-Won Hann, Jefferson Medical College, Philadelphia, PA USAEugene Schiff, University of Miami, Miami, FL USADavid Mutimer, Queen Elizabeth Hospital, Birmingham, UKBernard Willems, Hospital Saint Luc, Montreal, CanadaNancy Leung, Alice Ho Miu Ling Nethersole Hospital, Hong Kong, ChinaWilliam M. Lee, University of Texas Southwestern Medical Center, Dallas, TX USASusan Di...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319497</comments>
            <pubDate>Tue, 04 Jan 2011 17:54:57 +0100</pubDate>
            <guid isPermaLink="false">4319497</guid>        </item>
        <item>
            <title>A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=4303247&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqt96176881w83726%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Mean reduction of viral loads was similar between clevudine and entecavir groups during 48&amp;nbsp;weeks. However, virologic breakthrough
 and significant myopathy were noted only in clevudine-treated patients. Therefore, more attention should be paid to patients
 receiving clevudine.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9238-7Authors
		Su Rin Shin, Department of Medicine, Kangnam Sacred Heart Hospital, Hallym University, Seoul, KoreaByung Chul Yoo, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaMoon Seok Choi, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaDong Ho Lee, Digestive Disease Research Centre, Samsung Medical Centre, Seoul, K...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4303247</comments>
            <pubDate>Fri, 31 Dec 2010 18:04:09 +0100</pubDate>
            <guid isPermaLink="false">4303247</guid>        </item>
        <item>
            <title>Vertical transmission of hepatitis C virus in low to middle socio-economic pregnant population of Karachi</title>
            <link>http://www.medworm.com/index.php?rid=4302435&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj672046n773383w4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In spite of the high hepatitis C positivity in pregnant population, the rate of vertical transmission to the neonate is low.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9229-8Authors
		Sina Aziz, Sarwar Zuberi Liver Centre, Civil Hospital Karachi, Dow University of Health Sciences, Karachi, Sindh PakistanNazli Hossain, Gynaecology and Obstetrics, Civil Hospital Karachi, Dow University of Health Sciences, Karachi, Sindh PakistanSaadiya Aziz Karim, Gynaecology and Obstetrics, Abbasi Shaheed Hospital, Karachi Medical and Dental College, Karachi, Sindh PakistanJamila Rajper, Sarwar Zuberi Liver Centre, Civil Hospital Karachi, Dow University of Health Sciences, Karachi, Sindh PakistanNargis Soomro, Gynaecology and Obstetrics, Civil Hospital Karachi, Dow Unive...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4302435</comments>
            <pubDate>Thu, 30 Dec 2010 18:05:02 +0100</pubDate>
            <guid isPermaLink="false">4302435</guid>        </item>
        <item>
            <title>Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=4301179&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff111p5q4h7714888%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies have suggested that glutamine synthetase (GS) is a potential marker of hepatocellular carcinoma (HCC). We aimed to
 evaluate the expression of GS in non-malignant liver tissue and serum GS levels in HCC, liver cirrhosis (LC), chronic hepatitis
 B (CHB), five kinds of extrahepatic diseases patients and healthy subjects. Immunohistochemistry (IHC) was used to assess
 GS expression in 260 liver tissue samples (from 120 HCC, 90 CHB stage 4, and 50 CHB stage 1–3 patients). Enzyme-linked immunosorbent
 assays of 325 samples (from 100 healthy donors, 33 CHB stage 1–3, 43 CHB stage 4, 111 HCC, and 45 extrahepatic diseases patients)
 were used to further analyze GS levels in serum. IHC studies showed the expression of GS in 70% of HCC patients, 46.7% of
 CHB stage 4 ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301179</comments>
            <pubDate>Tue, 28 Dec 2010 15:15:24 +0100</pubDate>
            <guid isPermaLink="false">4301179</guid>        </item>
        <item>
            <title>Predictors of outcome in acute-on-chronic liver failure in children</title>
            <link>http://www.medworm.com/index.php?rid=4301180&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw5836k0005r7g8g8%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The mortality in ACLF is 19.4% and the causes of death were multiorgan failure and liver failure. The SOFA score and INR were
 predictors of outcome of ACLF in children.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9217-zAuthors
		Jeevan Lal, Pediatric Gastroenterology, Hepatology and Nutrition, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaB. R. Thapa, Pediatric Gastroenterology, Hepatology and Nutrition, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaPawan Rawal, Pediatric Gastroenterology, Hepatology and Nutrition, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 IndiaR. K. Ratho, Department of Virology, Post Graduate Institute of Medical Education a...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301180</comments>
            <pubDate>Tue, 28 Dec 2010 15:15:21 +0100</pubDate>
            <guid isPermaLink="false">4301180</guid>        </item>
        <item>
            <title>Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre</title>
            <link>http://www.medworm.com/index.php?rid=4301181&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd2372741683t4k55%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;DN incidence has decreased in recent years; however, as survival post-LT increases, so does the incidence of DN. Surveillance
 programmes are necessary to diagnose DN at early stages.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9231-1Authors
		Gonzalo Sapisochin, Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall D’Hebron, Universidad Autónoma de Barcelona, Barcelona, SpainItxarone Bilbao, Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall D’Hebron, Universidad Autónoma de Barcelona, Barcelona, SpainCristina Dopazo, Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall D’Hebron, Universidad Autónoma de Barcelona, Barcelon...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301181</comments>
            <pubDate>Tue, 28 Dec 2010 15:15:20 +0100</pubDate>
            <guid isPermaLink="false">4301181</guid>        </item>
        <item>
            <title>Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation</title>
            <link>http://www.medworm.com/index.php?rid=4296878&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc8013v0r38r2x457%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The long-term outcome after surgery for Child-Pugh class A and single small HCC is superior to that after RFA.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9237-8Authors
		Won Kyoung Yun, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaMoon Seok Choi, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaDongil Choi, Department of Radiology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaHyun-Chul Rhim, Department of Radiology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, KoreaJae Won Joh, Department of Surgery, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Ko...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4296878</comments>
            <pubDate>Fri, 24 Dec 2010 07:02:25 +0100</pubDate>
            <guid isPermaLink="false">4296878</guid>        </item>
        <item>
            <title>Caffeoyl pyrrolidine derivative LY52 inhibits hepatocellular carcinoma invasion via suppressing matrix metalloproteinase-2</title>
            <link>http://www.medworm.com/index.php?rid=4286173&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhwluh46762055gg0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results suggested that LY52 might inhibit the invasion of hepatocellular carcinoma cells by suppressing matrix metalloproteinase-2,
 although the inhibitory effects of LY52 on HBV-negative cells were more obvious than that of HBV-infected cells.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9234-yAuthors
		Xin Zhao, Hepato-Biliary Surgery Division, The No.302 Hospital of PLA, Beijing, ChinaHuanli Xu, Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanYoshinori Inagaki, Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanNorihiro Kokudo, Hepato-Biliary-Pancreatic Surgery Division, Departm...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4286173</comments>
            <pubDate>Mon, 20 Dec 2010 22:54:03 +0100</pubDate>
            <guid isPermaLink="false">4286173</guid>        </item>
        <item>
            <title>Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics</title>
            <link>http://www.medworm.com/index.php?rid=4286174&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F124659568024x414%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In cirrhotic patients with painful gynaecomastia, the use of eplerenone instead of spironolactone might reverse pain and seems
 to be safe and clinically acceptable option.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9235-xAuthors
		Georgios Dimitriadis, First Department of Internal Medicine, Democritus University of Thrace, GR-68100 Alexandroupolis, GreeceVasileios Papadopoulos, First Department of Internal Medicine, Democritus University of Thrace, GR-68100 Alexandroupolis, GreeceKonstantinos Mimidis, First Department of Internal Medicine, Democritus University of Thrace, GR-68100 Alexandroupolis, Greece
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4286174</comments>
            <pubDate>Mon, 20 Dec 2010 22:54:02 +0100</pubDate>
            <guid isPermaLink="false">4286174</guid>        </item>
        <item>
            <title>Hepatic vein waveforms in liver cirrhosis re-evaluated</title>
            <link>http://www.medworm.com/index.php?rid=4273204&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F03v3168883x82465%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study shows that the flat waveforms have no diagnostic value. Role of hepatic blood flow seems to be important suggesting
 hemodynamic changes rather than liver dysfunction as a plausible cause of change in waveforms.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9226-yAuthors
		Sudhamshu K.C., National Academy of Medical Sciences, Kathmandu, NepalDilip Sharma, National Academy of Medical Sciences, Kathmandu, NepalSaroj Prasad Chataut, National Academy of Medical Sciences, Kathmandu, Nepal
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273204</comments>
            <pubDate>Thu, 16 Dec 2010 06:54:55 +0100</pubDate>
            <guid isPermaLink="false">4273204</guid>        </item>
        <item>
            <title>Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation</title>
            <link>http://www.medworm.com/index.php?rid=4268168&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2278v71443807h43%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Female gender and baseline serum ALT level ≥1,000&amp;nbsp;IU/L were independent predictors of early HBeAg loss during lamivudine therapy
 in HBeAg-positive CHB patients with AE.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9227-xAuthors
		Cheng-Yuan Peng, Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, 404 TaiwanChih-Bin Chen, Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, 404 TaiwanHsueh-Chou Lai, Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, 404 TaiwanWen-Pang Su, Division of Hepatogastroente...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4268168</comments>
            <pubDate>Wed, 15 Dec 2010 20:47:57 +0100</pubDate>
            <guid isPermaLink="false">4268168</guid>        </item>
        <item>
            <title>Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients</title>
            <link>http://www.medworm.com/index.php?rid=4226886&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj01037l361078802%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Pro12Ala variation of the PPAR γ2 gene is associated with NAFLD and might play a role in the pathogenesis of NAFLD.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9225-zAuthors
		A. C. Gupta, G.B. Pant Hospital, Institute of Genomics &amp; Integrative Biology (IGIB), Jamia Millia Islamia University, Delhi, IndiaA. K. Chaudhory, Department of Gastroenterology, G.B. Pant Hospital, New Delhi, IndiaSukriti, Department of Gastroenterology, G.B. Pant Hospital, New Delhi, IndiaC. Pande, Department of Gastroenterology, G.B. Pant Hospital, New Delhi, IndiaP. Sakhuja, Department of Pathology, G.B. Pant Hospital, New Delhi, IndiaY. Singh, Allergy &amp; Infectious diseases, Institute of Genomics &amp; Integrative Biology (IGIB), Delhi, IndiaS. F. Basir, Department of Biosciences...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4226886</comments>
            <pubDate>Tue, 30 Nov 2010 17:55:13 +0100</pubDate>
            <guid isPermaLink="false">4226886</guid>        </item>
        <item>
            <title>Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=4141388&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F064766h245p05598%2F</link>
            <description>Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B
	Content Type Journal ArticleDOI 10.1007/s12072-010-9224-0Authors
		Yoshiyasu Karino, Department of Gastroenterology, Sapporo Kosei General Hospital, North 3, East 8, Chuo-ku, Sapporo, JapanJoji Toyota, Department of Gastroenterology, Sapporo Kosei General Hospital, North 3, East 8, Chuo-ku, Sapporo, JapanHiromitsu Kumada, Department of Hepatology, Toranomon Hospital, Tokyo, JapanYoshiaki Katano, Department of Gastroenterology, Graduate School of Medicine, Nagoya University, Aichi, JapanNamiki Izumi, Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, JapanHaruhiko Kobashi, Department of Gastroenterology and Hep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4141388</comments>
            <pubDate>Thu, 04 Nov 2010 17:51:21 +0100</pubDate>
            <guid isPermaLink="false">4141388</guid>        </item>
        <item>
            <title>Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4111141&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6n6734638286j460%2F</link>
            <description>We present a 25-year-old
 man with a history of Still’s disease who presented with fever, arthralgia, and elevated serum ferritin levels 6&amp;nbsp;months after
 undergoing liver transplantation for fulminant hepatic failure due to autoimmune hepatitis potentially triggered by infliximab
 therapy. Liver biopsy demonstrated features consistent with hemophagocytic syndrome. The patient was successfully treated
 with a course of high dose steroids and had complete resolution of his symptoms and normalization of liver chemistry test
 abnormalities. Patients with Still’s disease may rarely complicate with fulminant hepatic failure with infliximab therapy.
 Hemophagocytic syndrome a rare potentially life threatening condition may occur in such patients following liver transplantation.
 
 
	Conte...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4111141</comments>
            <pubDate>Sat, 23 Oct 2010 15:49:05 +0100</pubDate>
            <guid isPermaLink="false">4111141</guid>        </item>
        <item>
            <title>The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases</title>
            <link>http://www.medworm.com/index.php?rid=4090753&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38712140883k60j7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Toll-like receptor 4 (TLR4) is a pattern recognition receptor that functions as lipopolysaccharide (LPS) sensor and whose
 activation results in the production of several pro-inflammatory, antiviral, and anti-bacterial cytokines. TLR4 is expressed
 in several cells of healthy liver. Despite the constant confrontation of hepatic TLR4 with gut-derived LPS, the normal liver
 does not show signs of inflammation due to its low expression of TLR4 and ability to modulate TLR4 signaling. Nevertheless,
 there is accumulating evidence that altered LPS/TLR4 signaling is a key player in the pathogenesis of many chronic liver diseases
 (CLD). In this review, we first describe TLR4 structure, ligands, and signaling. Later, we review liver expression of TLR4
 and discuss the role of L...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4090753</comments>
            <pubDate>Wed, 20 Oct 2010 18:01:05 +0100</pubDate>
            <guid isPermaLink="false">4090753</guid>        </item>
        <item>
            <title>Spontaneous rupture of a giant hepatobiliary serous cystadenoma: report of a case and literature review</title>
            <link>http://www.medworm.com/index.php?rid=4069295&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw843l78437433377%2F</link>
            <description>We report a case of hepatobiliary serous cystadenoma with mesenchymal stroma, initially
 misdiagnosed as simple hepatic cyst with intracystic hemorrhage. The rapid growth of the giant tumor leads to spontaneous
 rupture, almost turned into a life-threatening event. After emergency formal liver resection, the patient recovered well without
 recurrence during the 6-month follow-up period. We also reviewed the literature, proposed possible factors for the tumor’s
 rapid growth, and discuss the current diagnostic and treatment modalities.
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9221-3Authors
		Yongliang Sun, Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, 1# Shuaifuyuan, Dongcheng District, Beijing, 100730 ChinaXin Lu, Department of Liver Surgery, P...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4069295</comments>
            <pubDate>Tue, 12 Oct 2010 05:59:50 +0100</pubDate>
            <guid isPermaLink="false">4069295</guid>        </item>
        <item>
            <title>Giant cystic lymphangioma of the liver</title>
            <link>http://www.medworm.com/index.php?rid=4062648&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyp11522257143665%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Surgical resection is an effective therapy in treating giant cystic lymphangioma.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9220-4Authors
		Liang Huang, First Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, #225 Changhai Road, Shanghai, 200438 People’s Republic of ChinaJing Li, First Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, #225 Changhai Road, Shanghai, 200438 People’s Republic of ChinaFeiguo Zhou, First Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, #225 Changhai Road, Shanghai, 200438 People’s Republic of ChinaJianjun Yan, First Department of Hepatic Surgery, Eas...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4062648</comments>
            <pubDate>Sat, 09 Oct 2010 16:51:22 +0100</pubDate>
            <guid isPermaLink="false">4062648</guid>        </item>
        <item>
            <title>Study of adiponectin in chronic liver disease and cholestasis</title>
            <link>http://www.medworm.com/index.php?rid=4062649&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk911552816k65104%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Adiponectin is elevated in cirrhosis and shows correlation with degree of hepatocellular injury and cholestasis. Finally,
 adiponectin levels in cirrhosis do not correlate with parameters of body composition or metabolism but exclusively with reduced
 liver function.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9216-0Authors
		Tary A. Salman, Hepatology, National Liver Institute, Menofeya University, Shebeen El-Kom, Menoufiya EgyptNaglaa Allam, Hepatology, National Liver Institute, Menofeya University, Shebeen El-Kom, Menoufiya EgyptGasser I. Azab, Hepatology, National Liver Institute, Menofeya University, Shebeen El-Kom, Menoufiya EgyptAhmed A. Shaarawy, Clinical Pathology, National Liver Institute, Menofeya University, Shebeen El-Kom, Menoufiya Egypt...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4062649</comments>
            <pubDate>Sat, 09 Oct 2010 05:59:51 +0100</pubDate>
            <guid isPermaLink="false">4062649</guid>        </item>
        <item>
            <title>Sclerosing cholangitis associated with retroperitoneal fibrosis: a case of multisystem fibroinflammatory disorder</title>
            <link>http://www.medworm.com/index.php?rid=4051941&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F41rxq5020511g32n%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The diagnosis of IgG4-related sclerosing disease should always be taken into consideration in patients with sclerosing cholangitis,
 especially when it is associated with any fibroinflammatory disorder.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9222-2Authors
		Grazyna T. Rompa, Department of Gastroenterology and Hepatology, Medical University of Gdansk, ul. Debinki 7, 80-211 Gdansk, PolandAnna K. Jablonska, Department of Gastroenterology and Hepatology, Medical University of Gdansk, ul. Debinki 7, 80-211 Gdansk, PolandMarek T. Guzek, Department of Gastroenterology and Hepatology, Medical University of Gdansk, ul. Debinki 7, 80-211 Gdansk, PolandMichal M. Dubowik, Department of Gastroenterology and Hepatology, Medical University of Gdansk, ul. Debinki...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4051941</comments>
            <pubDate>Thu, 07 Oct 2010 05:47:49 +0100</pubDate>
            <guid isPermaLink="false">4051941</guid>        </item>
        <item>
            <title>Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis</title>
            <link>http://www.medworm.com/index.php?rid=4051942&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb804675812626n13%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;LSM identified the risk group for HCC presence in chronic hepatitis patients and had high specificity in the prediction of
 HCC with the cut-off of 24&amp;nbsp;kPa.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9223-1Authors
		Yuan-Hung Kuo, Division of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Rd, Niao-Sung, Kaohsiung, 833 TaiwanSheng-Nan Lu, Division of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Rd, Niao-Sung, Kaohsiung, 833 TaiwanChao-Hung Hung, Division of Hepato-Gastroenterology, Department of Internal Medic...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4051942</comments>
            <pubDate>Thu, 07 Oct 2010 05:47:48 +0100</pubDate>
            <guid isPermaLink="false">4051942</guid>        </item>
        <item>
            <title>Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4002160&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn78m5jlx827r2133%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These results show the importance of maintaining the liver function and suggest that long-term IFN administration after RFA
 inhibits recurrence and contributes to an improved outcome in patients (in particular, IFN responders) who initially develop
 HCC.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9214-2Authors
		Soji Shimomura, Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501 JapanNaoto Ikeda, Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501 JapanMasaki Saito, Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4002160</comments>
            <pubDate>Fri, 24 Sep 2010 05:49:01 +0100</pubDate>
            <guid isPermaLink="false">4002160</guid>        </item>
        <item>
            <title>Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3999833&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F402r5v3453284021%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;For patients with solitary small HBV-related HCC who underwent resection, minimal fibrosis is associated with a lower incidence
 of recurrence and with better survival. APRI could serve as a reliable marker for assessing hepatic fibrosis and predicting
 survival.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9213-3Authors
		Hung-Hsu Hung, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanChien-Wei Su, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanChiung-Ru Lai, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, TaiwanGar-Yang Chau, Department of Medicine, Institute of Clinical Medicine, School of Medicine, N...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3999833</comments>
            <pubDate>Thu, 23 Sep 2010 17:00:46 +0100</pubDate>
            <guid isPermaLink="false">3999833</guid>        </item>
        <item>
            <title>Erratum to: Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein</title>
            <link>http://www.medworm.com/index.php?rid=3995866&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr525384l4232lxx8%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9212-4Authors
		Meta D. Thedja, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, IndonesiaMartono Roni, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, IndonesiaAlida R. Harahap, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, IndonesiaNurjati C. Siregar, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, IndonesiaSusan I. Ie, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, IndonesiaDavid H. Muljono, Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, Indonesia
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3995866</comments>
            <pubDate>Wed, 22 Sep 2010 05:53:41 +0100</pubDate>
            <guid isPermaLink="false">3995866</guid>        </item>
        <item>
            <title>Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin</title>
            <link>http://www.medworm.com/index.php?rid=3981596&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7w032x1662661717%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Intravenous PLD before RFA reduced contraction of ablative volume and might have no impact on tumor progression and survival
 in patients with small HCC after RFA.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9215-1Authors
		Jing-Houng Wang, Division of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Rd, Niaosung 833, Kaohsiung, TaiwanHung-Da Tung, Department of Gastroenterology, Chi Mei Foundation Hospital, Liouying, Tainan, TaiwanTai-Yi Chen, Department of Radiology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanChao-Hung Hung, Division of Hepato-Gastroenterology, De...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3981596</comments>
            <pubDate>Fri, 17 Sep 2010 06:51:30 +0100</pubDate>
            <guid isPermaLink="false">3981596</guid>        </item>
        <item>
            <title>Brush border enzymes and absorptive capacity in extrahepatic portal venous obstruction in children</title>
            <link>http://www.medworm.com/index.php?rid=3948484&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp14x712m22858x5v%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;EHPVO leads to decrease in levels of brush border enzymes in small bowel but their absorption capacity remains normal.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9211-5Authors
		Gurbakhshish Singh Sidhu, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Gastroenterology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 IndiaB. R. Thapa, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Gastroenterology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012 IndiaPawan Rawal, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Gastroenterology, Post Graduate Institute of Medical Education and Resear...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948484</comments>
            <pubDate>Tue, 07 Sep 2010 17:24:22 +0100</pubDate>
            <guid isPermaLink="false">3948484</guid>        </item>
        <item>
            <title>New antiviral therapies for chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=3883162&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyr52kn0l13570240%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic hepatitis C is an important health issue worldwide. The current standard therapy is based on a combination of pegylated-interferon
 (pegIFN) and ribavirin (RBV), but this treatment leads to only ~50% sustained virological response (SVR) in patients with
 HCV genotype 1 and high viral loads, who were mostly null-responders or relapsers. Among HCV genotypes other than HCV genotype
 1, especially HCV genotype 4 patients show only 40–70% SVR by this treatment. Although new drugs also depend on the combination
 of pegIFN and RBV, it appears that these drugs improve not only rapid virological response (RVR) but also early virological
 response, leading to SVR in these patients. In the near future, we predict higher SVR rates in chronic hepatitis C patients
 treated ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3883162</comments>
            <pubDate>Wed, 18 Aug 2010 06:49:34 +0100</pubDate>
            <guid isPermaLink="false">3883162</guid>        </item>
        <item>
            <title>Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt</title>
            <link>http://www.medworm.com/index.php?rid=3883161&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0q252t48634uv4n7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Occupational exposure may play an important role in the development of HCC. Farming, industrial exposures and cigarette smoking
 may increase the risk of HCC among HCV-seropositive individuals. Future research focusing on mechanisms of occupational exposures
 among HCV patients in this population is needed.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9187-1Authors
		Amr S. Soliman, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI USAChu-Wei Hung, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI USAAlexander Tsodikov, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI USAIbrahim A. Seifeldin, Tanta Cancer Center, Tanta, Gharbiah Egyp...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3883161</comments>
            <pubDate>Wed, 18 Aug 2010 06:49:34 +0100</pubDate>
            <guid isPermaLink="false">3883161</guid>        </item>
        <item>
            <title>Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission</title>
            <link>http://www.medworm.com/index.php?rid=3874209&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc62373q2055u5gm5%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The kind of fluidized-bed BLADs based on microencapsulated primary porcine hepatocytes have risk of PERVs transmission. Further
 extensive pre-clinical study focused on biosafety is warranted.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9210-6Authors
		Qian Yang, The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, 310003 ChinaFei Liu, The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, 310003 ChinaXiao Ping Pan, The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, 310003 ChinaGuoLiang Lv, The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, 310003 Ch...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3874209</comments>
            <pubDate>Sat, 14 Aug 2010 16:46:17 +0100</pubDate>
            <guid isPermaLink="false">3874209</guid>        </item>
        <item>
            <title>Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease</title>
            <link>http://www.medworm.com/index.php?rid=3866117&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F944127l2415p56u6%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our data showed that the decreased expression of hepatic FXR is associated with an increased expression of LXR, SREBP-1C,
 and hepatic triglyceride synthesis; furthermore, increased SREBP-1C is associated with the degree of hepatic steatosis in
 the NAFLD patients.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9202-6Authors
		Zhao-Xia Yang, Department of Gastroenterology and Hepatology, The Second Affiliated Hospital Chongqing Medical University, Chongqing, ChinaWei Shen, Department of Gastroenterology and Hepatology, The Second Affiliated Hospital Chongqing Medical University, Chongqing, ChinaHang Sun, Institute for Viral Hepatitis of Chongqing Medical University, Chongqing Medical University, Chongqing, China
	

	
		Journal Hepatology InternationalOnli...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3866117</comments>
            <pubDate>Thu, 12 Aug 2010 06:04:16 +0100</pubDate>
            <guid isPermaLink="false">3866117</guid>        </item>
        <item>
            <title>Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=3860066&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F305285t6w61130n1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients with CHB treated with Peg-IFN had fewer AEs than patients with CHC treated with Peg-IFN/ribavirin. All patients were
 treated safely.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9208-0Authors
		Jeng-Fu Yang, Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanYi-Hui Kao, School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanChia-Yen Dai, Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanJee-Fu Huang, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanMing-Yen Hsieh, Division of Hepatobiliary and Pa...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3860066</comments>
            <pubDate>Sun, 08 Aug 2010 17:04:03 +0100</pubDate>
            <guid isPermaLink="false">3860066</guid>        </item>
        <item>
            <title>Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=3860067&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc1k308551kr22545%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Asian (Non-South) race is a strong independent predictor of SVR.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9207-1Authors
		Venessa Pattullo, Division of Medicine, University Health Network, Toronto Western Hospital, Toronto, ON CanadaE. Jenny Heathcote, Division of Medicine, University Health Network, Toronto Western Hospital, Toronto, ON CanadaDavid K. H. Wong, Division of Medicine, University Health Network, Toronto Western Hospital, Toronto, ON Canada
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3860067</comments>
            <pubDate>Sat, 07 Aug 2010 16:49:43 +0100</pubDate>
            <guid isPermaLink="false">3860067</guid>        </item>
        <item>
            <title>Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization</title>
            <link>http://www.medworm.com/index.php?rid=3832560&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F235g138j65772543%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;TIPS alone showed a high incidence of rebleeding in this series, whereas TIPS with variceal embolization resulted in reduced
 recurrent hemorrhage. The efficacy of embolization during TIPS performed for variceal hemorrhage versus TIPS alone should
 be further compared with larger prospective randomized trials.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-010-9206-2Authors
		Ron C. Gaba, Interventional Radiology Section, Department of Radiology, University of Illinois Medical Center at Chicago, 1740 West Taylor Street, MC 931, Chicago, IL 60612, USAJames T. Bui, Interventional Radiology Section, Department of Radiology, University of Illinois Medical Center at Chicago, 1740 West Taylor Street, MC 931, Chicago, IL 60612, USAScott J. Cotler, Hepatology Sectio...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3832560</comments>
            <pubDate>Fri, 06 Aug 2010 07:14:17 +0100</pubDate>
            <guid isPermaLink="false">3832560</guid>        </item>
        <item>
            <title>Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression</title>
            <link>http://www.medworm.com/index.php?rid=3825194&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy4h106024t217873%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our preliminary data suggest that LSM can be used to assess liver fibrosis regression after antiviral treatment using nucleos(t)ide
 analogs in patients with CHB.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9201-7Authors
		Seung Up Kim, Yonsei University College of Medicine Department of Internal Medicine Seoul KoreaJun Yong Park, Yonsei University College of Medicine Department of Internal Medicine Seoul KoreaDo Young Kim, Yonsei University College of Medicine Department of Internal Medicine Seoul KoreaSang Hoon Ahn, Yonsei University College of Medicine Department of Internal Medicine Seoul KoreaEun Hee Choi, Yonsei University College of Medicine Department of Biostatistics Seoul KoreaJae Yeon Seok, Yonsei University College...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3825194</comments>
            <pubDate>Wed, 04 Aug 2010 08:06:31 +0100</pubDate>
            <guid isPermaLink="false">3825194</guid>        </item>
        <item>
            <title>Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients</title>
            <link>http://www.medworm.com/index.php?rid=3825195&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2l056632512x27m%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;CHC patients had a higher hs-CRP level than healthy controls which could be ameliorated after peginterferon/ribavirin combination
 therapy.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9200-8Authors
		Chung-Feng Huang, Kaohsiung Medical University Hospital Hepatobiliary Division, Department of Internal Medicine Kaohsiung TaiwanMing-Yen Hsieh, Kaohsiung Medical University Hospital Hepatobiliary Division, Department of Internal Medicine Kaohsiung TaiwanJeng-Fu Yang, Kaohsiung Medical University Hospital Hepatobiliary Division, Department of Internal Medicine Kaohsiung TaiwanWu-Cheng Chen, Kaohsiung Medical University Hospital Department of Preventive Medicine, Kaohsiung Municipal Ta-Tong Hospital Kaohsiung TaiwanMing-Lun Yeh, Kaoh...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3825195</comments>
            <pubDate>Wed, 04 Aug 2010 08:06:30 +0100</pubDate>
            <guid isPermaLink="false">3825195</guid>        </item>
        <item>
            <title>Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=3818720&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe4383t8075603522%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Sclerosing cholangitis caused by Langerhans cell histiocytosis is a rare condition in the adult population, but it has a high
 mortality. There is no definitive therapy other than liver transplantation. The long-term efficacy of liver transplantation
 remains unknown.
 
 
 
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-010-9205-3Authors
		Ibrahim Hatemi, Istanbul University Cerrahpasa Medical Faculty Division of Gastroenterology, Department of Internal Medicine 34098 Aksaray, Istanbul TurkeyBirol Baysal, Istanbul University Cerrahpasa Medical Faculty Division of Gastroenterology, Department of Internal Medicine 34098 Aksaray, Istanbul TurkeyHakan Senturk, Istanbul University Cerrahpasa Medical Faculty Division of Gastroenterology, Department of...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818720</comments>
            <pubDate>Tue, 03 Aug 2010 17:28:24 +0100</pubDate>
            <guid isPermaLink="false">3818720</guid>        </item>
        <item>
            <title>Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein</title>
            <link>http://www.medworm.com/index.php?rid=3818721&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdk437u56h448598g%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;OBI was detected in blood donors’ samples in Indonesia. Anti-HBc was shown to be a better screening parameter than HBsAg,
 however, it might result in the loss of donors particularly in endemic countries. HBsAg detection failure in this study might
 be due to mutations altering the protein antigenicity and/or the low-level carriage of HBV.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9203-5Authors
		Meta D. Thedja, Eijkman Institute for Molecular Biology Jl. Diponegoro 69 Jakarta IndonesiaMartono Roni, Eijkman Institute for Molecular Biology Jl. Diponegoro 69 Jakarta IndonesiaAlida R. Harahap, Eijkman Institute for Molecular Biology Jl. Diponegoro 69 Jakarta IndonesiaNurjati C. Siregar, Eijkman Institute for Molecular Biology...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818721</comments>
            <pubDate>Tue, 03 Aug 2010 15:01:21 +0100</pubDate>
            <guid isPermaLink="false">3818721</guid>        </item>
        <item>
            <title>Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=3818722&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57m7p7m3140k031t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ELISA is a practical and a useful method for HBV genotyping in a clinical setting in Taiwan, in particular for patients with
 lower levels of HBV DNA.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9198-yAuthors
		Shu-Fen Liu, Kaohsiung Medical University Hospital Hepatobiliary Division, Department of Internal Medicine Kaohsiung TaiwanMeng-Hsuan Hsieh, Kaohsiung Municipal HsiaoKang Hospital Department of Occupational Medicine Kaohsiung TaiwanNai-Jen Hou, Kaohsiung Municipal HsiaoKang Hospital Department of Internal Medicine Kaohsiung TaiwanMing-Yen Hsieh, Kaohsiung Medical University Faculty of Internal Medicine, College of Medicine Kaohsiung TaiwanJee-Fu Huang, Kaohsiung Municipal HsiaoKang Hospital Department of Internal Medici...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818722</comments>
            <pubDate>Tue, 03 Aug 2010 15:01:20 +0100</pubDate>
            <guid isPermaLink="false">3818722</guid>        </item>
        <item>
            <title>Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=3818723&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv17776x6w10g166g%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The comparison of clinical outcomes revealed that patients with HBV&amp;nbsp;+&amp;nbsp;HEV had more advanced baseline liver disease and a poorer
 prognosis than those with HBV&amp;nbsp;+&amp;nbsp;HAV. Because there is no vaccine against HEV, patients with CHB should take appropriate precautions
 against superinfection with HEV, such as consumption of boiled water and well-cooked food, in regions where it is endemic.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9204-4Authors
		Xiaohong Zhang, Third Affiliated Hospital of Sun Yat-Sen University Department of Infectious Diseases Shipai Guangzhou 510630 People’s Republic of ChinaWeimin Ke, Third Affiliated Hospital of Sun Yat-Sen University Department of Infectious Diseases Shipai Guangzhou 510...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818723</comments>
            <pubDate>Mon, 02 Aug 2010 19:24:03 +0100</pubDate>
            <guid isPermaLink="false">3818723</guid>        </item>
        <item>
            <title>A case–control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3818724&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0q0251350183650%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These data suggested that A1762T/G1764A and G1899A mutations were associated with the development of HCC in Thai patients.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9197-zAuthors
		Pisit Tangkijvanich, Chulalongkorn University Department of Biochemistry, Faculty of Medicine Bangkok 10330 ThailandPattaratida Sa-nguanmoo, Chulalongkorn University Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine Bangkok 10330 ThailandVarocha Mahachai, Chulalongkorn University Department of Medicine, Faculty of Medicine Bangkok 10330 ThailandApiradee Theamboonlers, Chulalongkorn University Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine Bangkok 10330 ThailandYong Poovo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3818724</comments>
            <pubDate>Mon, 02 Aug 2010 19:24:02 +0100</pubDate>
            <guid isPermaLink="false">3818724</guid>        </item>
        <item>
            <title>Spontaneous regression of a solitary necrotic nodule of the liver</title>
            <link>http://www.medworm.com/index.php?rid=3806891&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F501346v26j75q543%2F</link>
            <description>We present the case of an incidentally detected hepatic mass (diameter 2&amp;nbsp;cm) in a 35-year-old man.
 The hepatic mass was diagnosed as a solitary necrotic nodule by liver biopsy. Follow-up radiologic examination revealed that
 the solitary necrotic nodule had spontaneously regressed. This is the first report on the natural course history of a solitary
 necrotic nodule.
 
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-010-9199-xAuthors
		Chang Soo Choi, Wonkwang University Hospital Department of Internal Medicine, College of Medicine Iksan KoreaEun Young Cho, Wonkwang University Hospital Department of Internal Medicine, College of Medicine Iksan KoreaJin Soo Jeong, Wonkwang University Hospital Department of Internal Medicine, College of Medicine Iksan KoreaChong J...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3806891</comments>
            <pubDate>Thu, 29 Jul 2010 16:08:06 +0100</pubDate>
            <guid isPermaLink="false">3806891</guid>        </item>
        <item>
            <title>Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration</title>
            <link>http://www.medworm.com/index.php?rid=3806892&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl417m24728482636%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hepatocellular carcinoma (HCC) is naturally resistant to radiotherapy and cytotoxic chemotherapy, leaving surgery as the mainstream
 therapeutic approach. However, the 5-year recurrence rate after curative resection is as high as 61.5%. The background hepatitis
 B- or C-induced cirrhosis and the presence of micrometastases at the time of surgery have been regarded as two main causes
 of recurrence. Recently, accumulating evidence suggests that growth factors and cytokines released during the physiological
 process of post-surgical liver regeneration could induce the activation of dormant micrometastatic lesions. The establishment
 of neovasculature to support either liver regeneration or HCC growth involves multiple cell types including liver sinusoidal
 endothelial cel...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3806892</comments>
            <pubDate>Thu, 29 Jul 2010 16:08:04 +0100</pubDate>
            <guid isPermaLink="false">3806892</guid>        </item>
        <item>
            <title>Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers</title>
            <link>http://www.medworm.com/index.php?rid=3800365&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft112g7w82k77v580%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Nucleoside monotherapy is sufficient in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.
 HBV prophylaxis is necessary in anti-HBs-positive recipients of anti-HBc-positive donor livers.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9188-0Authors
		Watcharasak Chotiyaputta, University of Michigan Health System Division of Gastroenterology, Department of Internal Medicine Ann Arbor MI USAShawn J. Pelletier, University of Michigan Health System Division of Transplantation, Department of Surgery Ann Arbor MI USARobert J. Fontana, University of Michigan Health System Division of Gastroenterology, Department of Internal Medicine Ann Arbor MI USAAnna S. F. Lok, University of Michigan Health Syste...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800365</comments>
            <pubDate>Wed, 28 Jul 2010 17:45:48 +0100</pubDate>
            <guid isPermaLink="false">3800365</guid>        </item>
        <item>
            <title>Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis)</title>
            <link>http://www.medworm.com/index.php?rid=3800366&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa17307x5142x8806%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Various strategies of rhIL-2 administration play different roles in Con A-induced hepatitis, suggesting the importance of
 IL-2 administrative regime in clinical liver diseases.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9196-0Authors
		Xiaoang Zhang, University of Science and Technology of China Institute of Immunology, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences Hefei Anhui 230027 ChinaHua-Xing Wei, University of Science and Technology of China Institute of Immunology, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences Hefei Anhui 230027 ChinaSun Rui, University of Science and Technology of China Institute of Immunology, Hefei National Labor...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800366</comments>
            <pubDate>Wed, 28 Jul 2010 17:45:47 +0100</pubDate>
            <guid isPermaLink="false">3800366</guid>        </item>
        <item>
            <title>A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis</title>
            <link>http://www.medworm.com/index.php?rid=3800367&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh767828x0n2584j1%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;High-dose UCDA does not normalize aminotransaminase levels in patients with NASH. Other inexpensive well-tolerated agents
 for the treatment of NASH need to be investigated.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9195-1Authors
		Leon A. Adams, University of Western Australia School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Perth AustraliaPaul Angulo, Mayo Clinic Department of Gastroenterology and Hepatology Rochester USAJan Petz, Mayo Clinic Department of Gastroenterology and Hepatology Rochester USAJill Keach, Mayo Clinic Department of Gastroenterology and Hepatology Rochester USAKeith D. Lindor, Mayo Clinic Department of Gastroenterology and Hepatology Rochester USA
	

	
		Journal Hepatology Internation...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3800367</comments>
            <pubDate>Tue, 27 Jul 2010 19:46:51 +0100</pubDate>
            <guid isPermaLink="false">3800367</guid>        </item>
        <item>
            <title>Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study</title>
            <link>http://www.medworm.com/index.php?rid=3792146&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4232878177788034%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Vitamin D inadequacy and the severity of liver dysfunction move in parallel in patients with non-cholestatic CLD. Vitamin
 D assessment and replacement should be considered in the management of patients with non-cholestatic CLD.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9194-2Authors
		Arash Miroliaee, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranMohsen Nasiri-Toosi, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranOmid Khalilzadeh, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranAlireza Esteghamati, Tehran University of Medical Sciences Endocrinology and Metabolism Research Center (E...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3792146</comments>
            <pubDate>Sun, 25 Jul 2010 06:55:22 +0100</pubDate>
            <guid isPermaLink="false">3792146</guid>        </item>
        <item>
            <title>Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3792147&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6455154l47758k7%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These findings indicate that CTAP and CTHA are recommended for determining the stage of HCC, especially when the HCC nodule
 is larger than 30&amp;nbsp;mm in diameter.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9190-6Authors
		Hideki Ohnishi, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Gastroenterology and Hepatology 2-5-1 Shikata-cho Okayama Okayama 700-8558 JapanKohsaku Sakaguchi, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Gastroenterology and Hepatology 2-5-1 Shikata-cho Okayama Okayama 700-8558 JapanKazuhiro Nouso, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of G...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3792147</comments>
            <pubDate>Sat, 24 Jul 2010 20:06:36 +0100</pubDate>
            <guid isPermaLink="false">3792147</guid>        </item>
        <item>
            <title>Usefulness of multi-detector helical CT with multiplanar reconstruction for depicting the duodenal varices with multiple collateral shunt vessels</title>
            <link>http://www.medworm.com/index.php?rid=3792148&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4156173qp04310v%2F</link>
            <description>We report the case of a 58-year-old man with liver cirrhosis with repeated bleeding from duodenal
 varices. Esophagogastroduodenoscopy (EGD) revealed multinodular varices in the third portion of the duodenum. Then we conducted
 a capsule endoscopy (CE) and found fresh blood in the duodenum, suggesting duodenal variceal hemorrhage. Angiography depicted
 the varices with one afferent and two efferent vessels. Abdominal CT examination was conducted using a four-channel multi-detector
 row CT scanner. The multiplanar reconstructed images revealed not only the varices, but also three afferent and two efferent
 vessels. The patient was treated by surgical ligation and sclerotherapy, because of its complicated porto-systemic shunt and
 reserved liver function. No gastrointestinal bleeding has bee...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3792148</comments>
            <pubDate>Sat, 24 Jul 2010 13:51:54 +0100</pubDate>
            <guid isPermaLink="false">3792148</guid>        </item>
        <item>
            <title>Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=3792149&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd765654178tv3p77%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Liver stiffness was increased in patients with severe hepatitis B flares, with return to near normal levels by 6&amp;nbsp;months. Transient
 elastography for proper assessment of liver fibrosis should be performed at least 6&amp;nbsp;months after flare.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9189-zAuthors
		James Fung, The University of Hong Kong Department of Medicine, Queen Mary Hospital Hong Kong SAR ChinaChing-Lung Lai, The University of Hong Kong Department of Medicine, Queen Mary Hospital Hong Kong SAR ChinaDavid But, The University of Hong Kong Department of Medicine, Queen Mary Hospital Hong Kong SAR ChinaAxel Hsu, The University of Hong Kong Department of Medicine, Queen Mary Hospital Hong Kong SAR ChinaWai-Kay Seto, The ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3792149</comments>
            <pubDate>Sat, 24 Jul 2010 13:51:53 +0100</pubDate>
            <guid isPermaLink="false">3792149</guid>        </item>
        <item>
            <title>Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population</title>
            <link>http://www.medworm.com/index.php?rid=3755809&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv5532jw2067724r4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;PIVKA-II was more sensitive and specific than AFP for diagnosing HCC in the Indian population.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9186-2Authors
		Balkrishan Sharma, Postgraduate Institute of Medical Education and Research Department of Hepatology Chandigarh IndiaRadhika Srinivasan, Postgraduate Institute of Medical Education and Research Department of Cytopathology Chandigarh IndiaYogesh Kumar Chawla, Postgraduate Institute of Medical Education and Research Department of Hepatology Chandigarh IndiaShweta Kapil, Postgraduate Institute of Medical Education and Research Department of Hepatology Chandigarh IndiaNitin Saini, Postgraduate Institute of Medical Education and Research Department of Hepatology Chandigarh IndiaBhup...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3755809</comments>
            <pubDate>Tue, 13 Jul 2010 15:28:11 +0100</pubDate>
            <guid isPermaLink="false">3755809</guid>        </item>
        <item>
            <title>Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy</title>
            <link>http://www.medworm.com/index.php?rid=3741715&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn2843373h7436140%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Switching lamivudine-treated patients with chronic hepatitis B to entecavir results in increased virologic suppression with
 no evidence of resistance through 2&amp;nbsp;years of entecavir therapy. These findings support recommendations in the current Japanese
 treatment guidelines that stable lamivudine patients should be switched to entecavir.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9185-3Authors
		Tatsuya Ide, Kurume University School of Medicine Division of Gastroenterology, Department of Medicine Fukuoka JapanMichio Sata, Kurume University School of Medicine Division of Gastroenterology, Department of Medicine Fukuoka JapanKazuaki Chayama, Hiroshima University Department of Medicine and Molecular Science, Graduate School ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3741715</comments>
            <pubDate>Thu, 08 Jul 2010 12:09:15 +0100</pubDate>
            <guid isPermaLink="false">3741715</guid>        </item>
        <item>
            <title>Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection</title>
            <link>http://www.medworm.com/index.php?rid=3716020&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm700352p42q7x056%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings indicate a close association between chronic HBV infection and GERD, especially in female subjects and those
 with higher APRI levels. Moreover, HBV carriers with higher AST or TG levels have higher incidence of erosive esophagitis.
 The interactions between chronic HBV infection and GERD need further studies.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9184-4Authors
		Ching-Sheng Hsu, Buddhist Tzu Chi General Hospital Division of Gastroenterology, Department of Internal Medicine Taipei TaiwanChia-Chi Wang, Buddhist Tzu Chi General Hospital Division of Gastroenterology, Department of Internal Medicine Taipei TaiwanPin-Chao Wang, Buddhist Tzu Chi General Hospital Division of Gastroenterology, Department of Internal...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3716020</comments>
            <pubDate>Wed, 30 Jun 2010 15:23:12 +0100</pubDate>
            <guid isPermaLink="false">3716020</guid>        </item>
    </channel>
</rss>

